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ABSTRACT 
Glycosaminoglycans (GAGs) are long chains of negatively charged sulfated 
polysaccharides. They are often found to be covalently attached to proteins and form 
proteoglycans in the extracellular matrix (ECM). Many proteins bind GAGs through 
electrostatic interactions. GAG-binding proteins (GBPs) are involved in diverse 
physiological activities ranging from bacterial infections to cell-cell/cell-ECM contacts. 
This thesis is devoted to understanding how interactions between GBPs and their 
receptors modulate biological phenomena. Bacteria express GBPs on surface that 
facilitate dissemination and colonization by attaching to host ECM. The first GBP 
investigated in this thesis is decorin binding protein (DBP) found on the surface of 
Borrelia burgdorferi, causative pathogens in Lyme disease. DBPs bind GAGs of decorin, 
a proteoglycan in ECM. Of the two isoforms, DBPB is less studied than DBPA. In 
current work, structure of DBPB from B. burgdorferi and its GAG interactions were 
investigated using solution NMR techniques. DBPB adopts a five-helical structure, 
similar to DBPA. Despite similar GAG affinities, DBPB has its primary GAG-binding 
site on the lysine-rich C terminus, which is different from DBPA. Besides GAGs, GBPs 
in ECM also interact with cell surface receptors, such as integrins. Integrins belong to a 
big family of heterodimeric transmembrane proteins that receive extracellular cues and 
transmit signals bidirectionally to regulate cell adhesion, migration, growth and survival. 
The second part of this thesis focuses on αM I-domain of the promiscuous integrin αMβ2 
(Mac-1 or CD11b/CD18) and explores the structural mechanism of αM I-domain 
interactions with pleiotrophin (PTN) and platelet factor 4 (PF4), which are cationic 
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proteins with high GAG affinities. After completing the backbone assignment of αM I-
domain, paramagnetic relaxation enhancement (PRE) experiments were performed to 
show that both PTN and PF4 bind αM I-domain using  metal ion dependent adhesion site 
(MIDAS) in an Mg
2+
 independent way, which differs from the classical Mg
2+
 dependent 
mechanism used by all known integrin ligands thus far. In addition, NMR relaxation 
dispersion analysis revealed unique inherent conformational dynamics in αM I-domain 
centered around MIDAS and the crucial C-terminal helix. These dynamic motions are 
potentially functionally relevant and may explain the ligand promiscuity of the receptor, 
but requires further studies. 
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CHAPTER 1 
INTRODUCTION 
1.1 Glycosaminoglycan (GAG)-binding Proteins (GBPs) 
Glycosaminoglycans are long negatively charged heteropolysaccharide chains of 
repeating disaccharide units of an amino sugar and a uronic acid. Depending on 
disaccharide unit composition and sulfation pattern, GAGs can be classified into the 
following categories: hyaluronic acid (HA), chondroitin sulfate (CS), dermatan sulfate 
(DS), keratin sulfate (KS), heparan sulfate (HS) and heparin (HP). Details of the 
aforementioned GAG composition and properties are summarized in Table 1.1 (1).  Most 
GAGs, except for HA, are covalently attached to core proteins to form entities known as 
proteoglycan (PG), often found on cell surface or extracellular matrix (ECM). Of all 
GAG types, heparan sulfate (HS) and heparin (HP) are probably the most studied due to 
their high affinities for protein ligands. Structures of major GAG disaccharide units are 
illustrated in Figure 1.1 (2).  
GAGs are known to bind to a broad spectrum of proteins. The number of GAG-
binding proteins (GBPs) is estimated to be several hundred (3,4). Among them are 
chemokines, growth factors, enzyme inhibitors and extracellular matrix (ECM) proteins 
(5,6). Through various protein ligands, GAGs mediate multiple processes through 
modulation of cell-cell and cell-ECM interactions. These include development and 
differentiation, immune response (inflammation), cancer, infectious diseases and 
neurodegenerative diseases (2,7-19). Some of previously reported GBPs are summarized 
in Table 1.2 (20). GAG bindings have various effects on proteins, including but not 
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limited to, protection from proteolysis, regulation of binding to other proteins, protein 
oligomerization, modulation of enzyme activity and immobilization of proteins (21). 
Most GBPs identified interact with heparin/heparan sulfate with high affinity due to high 
sulfation content, in contrast to the relatively small number of proteins that bind CS, DS 
or KS specifically (21).  
 
Table 1.1 Composition and Property of GAGs. 
Reprinted with permission from Kamhi, E., Joo, E. J., Dordick, J. S., and Linhardt, R. J. 
(2013) Glycosaminoglycans in infectious disease. Biological reviews of the Cambridge 
Philosophical Society 88, 928-943. Copyright (2013) John Wiley and Sons. See Appendix 
C. 
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Figure 1.1 Structures of Repeating Disaccharide Units in Common GAGs. 
Reprinted with permission from Linhardt, R. J., and Toida, T. (2004) Role of 
glycosaminoglycans in cellular communication. Accounts of chemical research 37, 431-
438. Copyright (2004) American Chemical Society. See Appendix D. 
 
 
Table 1.2 A list of Reported GAG-binding Proteins. 
Reprinted with permission from Zhang, L. (2010) Glycosaminoglycan (GAG) 
biosynthesis and GAG-binding proteins. Progress in molecular biology and translational 
science 93, 1-17. Copyright (2010) Elsevier. See Appendix E. 
 
1.2 Protein-glycosaminoglycan Interactions 
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Protein-GAG bindings are dominated by electrostatic interactions between 
positively charged basic residues in proteins and negatively charged GAG chains. The 
premise leads researchers to investigate if consensus sequences for GAG binding exist in 
protein ligands. As the most negatively charged GAG type, heparin has been heavily used 
in investigations of GAG-protein systems. The first study was reported in 1989 by Cardin 
and Weintraub (22). They proposed two binding motifs after studying GAG-binding 
regions of four heparin-binding proteins (apolipoproteins B, apolipoprotein E, vitronectin 
and platelet factor 4). The two binding motifs are XBBXBX and XBBBXXBX, in which 
B denotes basic amino acids (lysine, arginine and histidine) and X denotes hydropathic 
(neutral and hydrophobic) amino acids (alanine, glycine, isoleucine, leucine and tyrosine). 
These motifs were also identified in other heparin-binding proteins. In their modeling, 
when these motifs reside in β strands, basic residues would be oriented on one side while 
hydrophobic residues are positioned on the opposite side, pointing toward the protein 
core. When the motif is on α helix, basic residues are concentrated on one side of the 
helix while hydrophobic residues are located back towards the protein core. These 
arrangements facilitate binding of negatively charged GAGs to positively charged 
residues in proteins. Using the same strategy, a third consensus sequence, 
XBBBXXBBBXXBBX, was discovered from another heparin binding protein, von 
Willebrand factor, by Sobel et al. (23).  
However, further investigations revealed that the previously proposed motifs do 
not apply in all cases. Basic residues that are not close in sequence may be positioned 
close in the folded conformation as the GAG binding site. An excellent example is the 
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observation made by Margalit et al. (24). Using molecular modeling, they revealed that 
the ~ 20 Å distance between basic amino acids on opposite sides of the protein is 
essential for heparin bindings, whether the residues are on  helix or  strand. In this 
scenario, the heparin molecule coils around the protein in such a way to bind sequence-
distant basic residues, with the possibility of inducing conformational changes. 
Other factors also affect GAG-protein bindings. Basic amino acid type is one of 
them. Arginines bind GAGs with 2.5-fold higher affinity than lysines. This is likely to be 
a result of stronger hydrogen bonding between the guanidine group of arginine and the 
sulphate of heparin (25).  In addition, basic amino acid pattern and spacing influence 
GAG bindings. Synthetic peptides with different positive charge density, -RRGmRR- and 
-RRRGmR-, were tested with heparin and heparin sulfate. Highly sulfated heparin binds 
tighter with higher charge density -RRRGmR- motif while less sulfated heparan sulfate 
binds tighter with lower charge density -RRGmRR- motif (26). As GAG bindings involve 
spatially close basic residues in a binding surface with only a small segment of GAG 
chains, one single long GAG chain could interact with multiple proteins at different sites 
in a way that facilitates cooperative binding and possibly leads to protein oligomerization 
(21).  
1.3 Functions Of Glycosaminoglycan-binding Proteins (GBPs) in Bacterial Infection. 
 Since most GAGs are incorporated into proteoglycans displayed on cell surface or 
in ECM, GAGs and GBPs primarily mediate cell-cell and cell-ECM interactions. 
Pathogen-cell contact exemplifies such interactions. Accumulating evidences indicate 
that GAG bindings are associated with enhanced viral and bacterial infection (27). As 
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eukaryotic cells and pathogens both have GAGs on surface, surface proteins on 
pathogens bind to host cell GAGs and vice versa, mediating adhesion and invasion onto 
host cells (27). For bacterial pathogenesis, a key step is attachment onto and colonization 
of host cells. As host cells are glycosylated, GBPs on bacterial surface provide initial 
“weak” contact with host cells, thus facilitating subsequent binding to host cell surface 
receptors with more stable interactions (28,29). GAG-protein interactions also contribute 
to bacterial infections by promoting bacterial internalization into host cells or by blocking 
access of cationic antimicrobial proteins to host cells with GAGs (30-32).  
Examples of bacterial GBPs are adhesins on Borrelia burgdorferi, the causative 
pathogen of Lyme disease. Lyme disease is the most commonly found tick-borne disease 
in the Northern Hemisphere (33,34). Its symptoms range from the classical erythema 
migrans (bull’s-eye rash skin lesion) in the early stage and neurological and 
cardiovascular manifestations in the secondary stage to arthritis in the late stage (34). 
Lyme disease is transmitted through ixodid ticks infected with Borrelia bacteria. The 
specific strain of pathogen causing Lyme disease in North America is Borrelia 
burgdorferi (34,35). 
B. burgdorferi expresses many GAG-binding lipoproteins on surface. These 
lipoproteins are crucial for the spirochete dissemination and immune invasion (35). Two 
well-known lipoproteins are decorin binding proteins A and B (DBPA/DBPB). DBPs 
bind DS chains of decorin (36,37). Besides DS, DBPs also bind other GAGs, such as HP 
and HS (38-40).  As a matter of fact, HP binds DBPs with a higher affinity than DS due 
to its high sulfation density (40). DBPA has a lower sequence homology (~ 40 %) than 
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DBPB (~ 60 - 99.5 %) among difference strains (41,42). Although both contribute to the 
overall virulence, DBPA and DBPB have unequal effects in dissemination and 
colonization (43). As sequences of DBPB are less heterogeneous, it is a potentially more 
valuable therapeutic target. There have been more studies on DBPA than DBPB. First 
structure of DBPA was determined with solution NMR in 2012 (40). As shown in Figure 
1.2, B31 version of DBPA adopts a five-helix structure and contains a basic patch as the 
GAG-binding site. The basic patch consists of C terminus, the linker between helices 1 
and 2, and parts of helices 2 and 5, revealed by electrostatic potential mapping (40). A 
later study using X-ray crystallography confirmed the structure (44). 
 
Figure 1.2 Electrostatic Potential Surface Map of B31 DBPA.  
Surface is color coded with red for acidic and blue for basic regions. (A) and (B) are 
different orientations with 90° rotation about the vertical axis.  
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Reprinted with permission from Wang, X. (2012) Solution structure of decorin-binding 
protein A from Borrelia burgdorferi. Biochemistry 51, 8353-8362. Copyright (2012) 
American Chemical Society. See Appendix F. 
Current work on DBPB will be explored in Chapter 2. Using solution NMR, B31 
DBPB structure was determined. Although DBPA and DBPB have similar GAG binding 
affinities, GAG-binding epitopes on DBPB are different from DBPA. 
1.4 Non-Proteoglycan Receptors for GAG-binding Proteins (GBPs) 
Extracellular matrix (ECM) is a key feature of multi-cellular eukaryotic 
organisms. This complex multi-component network is composed of polysaccharides and 
proteins (45). ECM provides dynamic environments needed for cell survival, migration, 
differentiation and tissue organization (45,46). As discussed above, many GBPs reside in 
ECM due to the abundance of GAGs in ECM. Surprisingly, many non-proteoglycan cell 
surface receptors recognize and bind cationic proteins, many of which are also GBPs. 
One of these non-proteoglycan receptors is integrin. Through binding ECM components, 
integrin mediate cell adhesion, migration, growth and survival (47). Integrin evolved 
early in metazoan history and all multi-cellular animals express the protein (48). In fact, 
integrin is so named for its role as integral membrane proteins that connect ECM and 
cytoskeleton network (49). All integrins are composed of non-covalently bound α and β 
subunits. Both α and β chains are type-1 transmembrane proteins with large extracellular 
domains and small cytosolic domains. α and β chains have around 1000 and 750 amino 
acid residues respectively. In vertebrates, 24 types of heterodimers are formed through 
assembly of 18 α and 8 β subunits (47). 9 out of the 18 α subunits contain an extra 
inserted domain, known as α I or α A domain (50). Based on this domain, the protein 
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family can be categorized into α I-domain containing integrins and α I-domain less 
integrins. The following discussions will focus on α I-domain containing integrins. 
A complete understanding of how integrin functions is not possible without 
solving the structure of integrin. The long-awaited breakthrough was made in 2001 by 
Xiong et al. (51). They determined the extracellular domain structure of integrin αvβ3. 
This was followed by structures solved for αIIbβ3 (52) and αxβ2 (53). Surprisingly, all 
these crystal structures display “bent” conformations with N-terminal ligand binding 
regions (head) oriented close to where membrane surface would be in vivo, making the 
headpieces less accessible to ligands. Integrin domain organizations and ectodomain 
structure of αxβ2 are illustrated in Figure 1.3 (52,53). As shown in Figure 1.3, α chain 
contains a seven-bladed β-propeller, a thigh domain, two calf domains followed by a 
transmembrane domain and an intracellular domain. α I-domain is inserted between the 
second and third blades of β-propeller in α I-domain containing integrins (50). A similar I 
domain is also found in β chain. β I-domain is inserted in hybrid domains which are 
flanked by plexin-semaphorin-integrin (PSI) domains, on top of four epidermal growth 
factor (EGF) domains, a β-tail, a transmembrane domain and an intracellular domain. 
Bend is located in the leg region between thigh and calf-1 on α subunit and, between 
EGF-1 and EGF-2 on β subunit (52-54). 
The discovery of the “bent” topology was unexpected as earlier observations from 
low resolution electron microscopy (EM) studies showed that the globular N-terminal 
extracellular regions (head) sit on long legs in an open/extended manner (55-62). Later on, 
accumulating evidences suggested that multiple conformations exist, including bent and 
10 
 
extended (63,64). Recent advances in super-resolution microscopy provided direct optical 
measurements of integrin extension from the membrane on cell surface (65,66). The 
global structural rearrangement is involved in integrin activation, as proposed in the 
switchblade model (47). The switchblade model postulates large scale of “bent to 
extended” conformational changes as shown in shown in Figure 1.4 (47). 
As displayed in Figure 1.4, integrins exist in three different conformations: bent 
(closed), extended (closed) and extended (open). Disruption of weak interactions that 
stabilize the bent conformation would lead to straightening of the ectodomains. In α I-
domain containing integrins, α I-domain serves as the primary ligand binding site. 
Specifically, an acidic residue in α I-domain serves as an intrinsic ligand for β I-domain. 
When this intrinsic ligand binds metal ion dependent adhesion site (MIDAS) of β I-
domain, a downward movement of ~ 10 Å in the α7 helix of α I-domain would further 
induce structural rearrangements in its MIDAS and lead to enhanced ligand bindings 
(47,67). 
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Figure 1.4 Structural Rearrangements in Activation of α I-domain Containing 
Integrins. 
Reprinted with permission from Luo, B. H., Carman, C. V., and Springer, T. A. (2007) 
Structural basis of integrin regulation and signaling. Annual review of immunology 25, 
619-647. Copyright (2007) ANNUAL REVIEWS.  See Appendix H. 
 
Many integrins have broad ligand binding specificities. Integrin αMβ2 (Mac-1 or 
CD11b/CD18) in fact is one of the most promiscuous members of integrin family. Over 
40 ligands have been identified and more are expected (68). A recent study discovered 
that Mac-1 has high binding affinity for peptides with high occurrence of basic amino 
acids (68). As the ligand binding site of Mac-1, αM I-domain was investigated in current 
studies with cationic ligands. Two proteins, pleiotrophin (PTN) and platelet factor 4 
(PF4), were selected. PTN is a cytokine while PF4 is a chemokine. Both PTN and PF4 
Figure 1.3 Crystal Structure of Integrins αxβ2 Ectodomains.  
Structures are extended on the right for clear visualization of domain organizations.  
Reprinted with permission from Xie, C., Zhu, J., Chen, X., Mi, L., Nishida, N., and Springer, 
T. A. (2010) Structure of an integrin with an alphaI domain, complement receptor type 4. 
The EMBO journal 29, 666-679. Copyright (2010) John Wiley and Sons. See Appendix G. 
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are highly positively charged and have high binding affinity for GAGs (69,70). They 
have been found to interact with Mac-1 and induce leukocyte responses through Mac-1. 
Binding sites for PTN and PF4 are localized to αM I-domain in Mac-1 (71,72). Current 
works aim to investigate structural biology of αM I-domain interaction with cationic 
ligands, and the conformational dynamics of αM I-domain using NMR techniques. 
Chapter 3 is on the NMR backbone assignment of αM I-domain. Chapter 4 explores the 
novel interaction mechanism of αM I-domain with cationic ligands. Chapter 5 focuses on 
preliminary characterization of αM I-domain dynamics using NMR relaxation dispersion 
experiments.  
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CHAPTER 2 
STRUCTURE OF DECORIN BINDING PROTEIN B FROM BORRELIA 
BURGDORFERI AND ITS INTERACTIONS WITH GLYCOSAMINOGLYCANS 
(Reprinted with permission from Feng, W., and Wang, X. (2015) Structure of decorin 
binding protein B from Borrelia burgdorferi and its interactions with 
glycosaminoglycans. Biochimica et biophysica acta 1854, 1823-1832. Copyright (2015) 
Elsevier. See Appendix I.) 
2.1 Abstract 
Decorin-binding proteins (DBPs), DBPA and DBPB, are surface lipoproteins on 
Borrelia burgdorferi, causative agent of Lyme disease. DBPs bind to the connective 
tissue proteoglycan decorin and facilitate tissue colonization by the bacterium. Although 
structural and biochemical properties of DBPA are well understood, little is known about 
DBPB. In current work, we determined the solution structure of DBPB from strain B31 
of B. burgdorferi and characterized its interactions with glycosaminoglycans (GAGs). 
Our structure shows DBPB adopts the same topology as DBPA, but possesses a much 
shorter terminal helix, resulting in a longer unstructured C-terminal tail, which is also 
rich in basic amino acids. Characterization of DBPB-GAG interactions reveals that, 
despite similar GAG affinities of DBPA and DBPB, the primary GAG-binding sites in 
DBPB are different from DBPA. In particular, our results indicate lysines in the C-
terminus of DBPB are vital to DBPB’s ability to bind GAGs whereas C-terminal tail for 
DBPA from strain B31 only plays a minor role in facilitating GAG bindings. Furthermore, 
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the traditional GAG-binding pocket important to DBPA-GAG interactions is only 
secondary to DBPB’s GAG-binding ability. 
2.2 Introduction 
Borrelia burgdorferi is the causative agent of Lyme disease, which is the most 
prevalent vector-borne disease in North America. As an extracellular bacterium, B. 
burgdorferi relies almost entirely on host cells for nutrients. Because of its parasitic life 
cycle, B. burgdorferi has developed many strategies for adhering to and evading 
detection by the host. Many of the proteins involved in promoting the adhesion of the 
bacteria to the host cells have shown to be important to the virulence of the bacteria (1,2). 
Understanding the mechanisms of these virulent factors is therefore an important aspect 
in tackling B. burgdorferi infection.  
One of the B. burgdorferi adhesins identified is decorin binding protein (DBP), a 
cell surface lipoprotein that is expressed during the mammalian infection stage (3). Two 
homologous forms of DBP, termed DBPA and DBPB, exist in the B. burgdorferi genome. 
Both are lipoproteins of approximately 20 kDa in size, and they share ~ 40 % sequence 
identity. Genetic studies of the two isoforms show both are important for the bacteria 
during early stages of infection (4-6). Although the two isoforms can compensate one 
another to a limited extent, absence of either one can produce defects in joint colonization 
and DBPB overexpression also inhibits proper dissemination of the bacterium (7,8). 
Interestingly, DBPA shows high sequence diversity among different strains of Borrelia 
bacteria, while DBPB sequence is well conserved (9-11).  
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DBPs facilitate bacterial colonization by adhering to proteoglycans in the 
extracellular matrix (ECM) and on cell surfaces. The ECM proteoglycan decorin is a 
particular important target for DBPs (3,12), and the glycosaminoglycan (GAG) portion of 
decorin is a major binding site for the DBPs (13-15). GAGs are sulfated linear 
polysaccharides composed of repeating disaccharide units of uronic acids and amino 
sugars (16). Because of their high sulfation density and large size, GAGs have strong 
interactions with a number of extracellular proteins via electrostatic interactions. This 
enables them to act as receptors for signaling proteins and microbes. Although the GAG 
chains found in decorin are either chondroitin sulfate (CS) or dermatan sulfate (DS), 
which contain N-acetylgalactosamine (GalNAc) only, DBPs are also known to interact 
with other GAG types including heparin and heparan sulfate (HS), both of which contain 
glucosamine instead of GalNAc. In fact, DBPA’s affinity for heparin is significantly 
higher than its affinity for DS (9,13,14,17). The core protein of decorin is also suspected 
to play a role in facilitating the interactions between decorin and DBPs (12,13). However, 
there is yet no evidence of direct interactions between the decorin core protein and DBPs. 
Although DBPA has been extensively studied functionally and structurally 
(10,13,18,19), very little information is available on DBPB. The lack of information is 
curious considering that one reason for the interest in DBPs is their potential as vaccine 
components. However, the high genetic diversity of DBPA means a single vaccine may 
not be sufficient in eliciting immunity against all strains of the bacterium. In this respect, 
DBPB, whose sequence is well conserved among different strains, may be a better 
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candidate for vaccine development. In fact, antibody against DBPB has been one of the 
most common antibodies found in serums of humans infected with the bacterium (20). 
We have determined the solution structure of DBPB from strain B31 of Borrelia 
burgdorferi using solution NMR and characterized its interactions with GAGs. Structure 
of DBPB is homologous to the known DBPA structures. In particular, it is composed of 
five helices with an unstructured linker between helices one and two as well as a flexible 
C-terminal tail. However, the C-terminal helix of DBPB is considerably shorter than the 
helix in DBPA, resulting in a longer unstructured C-terminal tail that is enriched in basic 
amino acids. Characterizations of DBPB-GAG interactions showed DBPB has similar 
GAG affinities as DBPA, but possesses different binding sites than DBPA. In particular, 
although some of the lysine residues deemed important to DBPA’s affinity for GAGs are 
also conserved in DBPB, the most important GAG-binding site in DBPB is its lysine-rich 
C-terminus, the elimination of which reduced the GAG affinity of DBPB significantly. 
These results indicate DBPB may be as important in facilitating bacterial adhesion as the 
well-studied DBPA. 
2.3 Materials and Methods 
1, Expression and purification of B31 DBPB 
The open reading frame (ORF) of the wild type (WT) B31 DBPB (residues 21-
187) was synthesized by Genscript Inc. (Piscataway, NJ) and cloned into the pHUE 
vector with ORF of His-tagged ubiquitin at the 5’ end (21). Residue C21, which acts as 
the lipid anchor in vivo, was mutated to serine to prevent dimerization (3). To construct 
DBPB mutants, the following forward primers were designed: K65S/K69S, 5’-
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GCGTTCACCGGCCTGAGCACGGGTAGCAGCGTTACCTCTGG-3’; R78S/K81S, 
5’-GGCGGTCTGGCCCTGAGCGAAGCAAGCGTGCAGGCGATTG-3’; K81S, 5'-
GGCCCTGCGCGAAGCAAGCGTGCAGGCGATTGTG-3'; K169S, 5'-
GAAAGTGGTTAAAGAAAGCCAGAACATCGAAAACGG-3'; 
184
SSSS
187
, 5’-
GGGCTCCGCGGTGGATCGAGC-3’; DBPB21-183, 5’-
GAAAAACAACAAAAGCTAAAAGAAAAAATGAAAG-3’. The reverse primers 
were designed: K65S/K69S, 5’-
CCAGAGGTAACGCTGCTACCCGTGCTCAGGCCGGTGAACGC-3’; R78S/K81S, 
5’-CAATCGCCTGCACGCTTGCTTCGCTCAGGGCCAGACCGCC-3’; K81S, 5'-
CAACAATCGCCTGCACGCTTGCTTCGCGCAGGGCC-3'; K169S, 5'-
CCGTTTTCGATGTTCTGGCTTTCTTTAACCACTTTC-3'; 
184
SSSS
187
 5’-
GGGAAGCTTTCAGCTGCTGCTGCTGCTTTTGTTGTTTTT-3’; DBPB21-183, 5’-
CTTTCATTTTTTCTTTTAGCTTTTGTTGTTTTTC-3’. The mutagenesis was done 
with the Agilent Quickchange site-directed mutagenesis kit according to the 
manufacturer’s protocol, and confirmed by sequencing. 
Escherichia coli BL21 (DE3) cells transformed with the expression vectors were 
grown in M9 medium at 37 °C to an OD600 of 0.8. The cells were then induced with 0.5 
mM IPTG before overnight incubation at 30 °C. 
15
NH4Cl and/or 
13
C glucose were added 
into M9 medium for desired isotopic labeling. After cell harvesting by centrifugation, the 
resuspended cells were treated with 1 mg/mL lysozyme for 20 min and lysed via 
sonication. After centrifugation, the supernatant was subjected to Ni-affinity 
chromatography with a 5 mL HisTrap column (GE Life Sciences). The bound DBPB was 
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eluted from the column by applying an imidazole gradient of 35 to 500 mM at a flow rate 
of 3 mL/min. After exchanging the pooled protein into 25 mM Tris and 100 mM NaCl 
buffer (pH 8.0), the fusion protein was cleaved with 1/20 molar equivalent of USP2 
(deubiquitinase) overnight at room temperature (21). Another Ni-affinity chromatography 
was applied to separate cleaved DBPB from His-tagged ubiquitin and His-tagged USP2.  
2, Production of GAG fragments and TEMPO-labeled GAG fragments 
Heparin and DS from Sigma-Aldrich were partially depolymerized using 
heparinase I (IBEX Inc.) and chondroitinase ABC (Sigma-Aldrich), respectively (22,23). 
Digested fragments were separated based on size with a 2.5 cm × 175 cm size exclusion 
chromatography column (Bio-Rad Biogel P10) at a flow rate of 0.2 mL/min. Fractions 
containing fragments of the same size were pooled, desalted, and lyophilized. For 
paramagnetic relaxation enhancement (PRE) studies, DS dodecasaccharide, or dp12 
(degree of polymerization 12) fragments were paramagnetically labeled by modifying the 
reducing end with the nitroxide radical, 4-amino-TEMPO, through reductive amination 
(19). Specifically, 300 uM TEMPO was mixed with 1 mg of GAG fragments and 25 mM 
NaCNBH3, and incubated at 65 °C for three days. After desalting, labeled fragments were 
further purified using SAX-HPLC. 
3, Acquisition and analysis of NMR data for DBPB structure and backbone dynamics 
NMR experiments were conducted on Bruker Ultra-Shield 600 MHz and Varian 
Inova 800 MHz spectrometers.  Most of the pulse sequences were provided by the 
manufacturer. For backbone assignment, HNCACB, HNCOCACB, HNCO, and 
HNCOCA spectra were acquired for 
13
C- and 
15
N-labeled DBPB. To determine DBPB 
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structure, 
15
N- and 
13
C-edited NOESY-HSQC spectra were obtained for 
13
C- and 
15
N-
labeled DBPB. Methyl group assignments were made with the methyl HCCH-TOCSY 
experiments (24) while side chain proton assignments were made using a combination of 
HCCH-TOCSY, HCCONH and 
13
C-edited NOESY-HSQC. HN and NC residual dipolar 
couplings (RDCs) were measured with DBPB aligned in a 7% neutral polyacrylamide gel 
using J-modulated pulse sequences (25). NMR samples contain 100-600 uM of 
13
C- 
and/or 
15
N-labeled DBPB in 50 mM NaH2PO4 and 150 mM NaCl buffer (pH 6.5). All 
NMR data were processed with NMRPipe (26) and analyzed using NMRView (27). 
For PRE studies, 400 uL of 150 uM WT 
15
N-labeled DBPB was mixed with 8 
molar equivalents of TEMPO-labeled DS dp12. PRE effect arising from the TEMPO-
labeled fragments was estimated by collecting a 
1
H-
15
N HSQC spectrum before and after 
the radical was reduced by adding 3 uL of 1 M ascorbic acid (28). 
To investigate the effects of GAG-binding on backbone mobility, backbone 
nitrogen T1, T2, and steady state heteronuclear nuclear Overhauser effect (NOE) were 
measured for WT 
15
N-labeled DBPB with or without 10 molar equivalents of heparin 
dp10. Relaxation delays for longitudinal relaxation (T1) and transverse relaxation (T2) 
experiments were 0.1, 0.25, 0.4, 0.6, 0.8, 1.0 s and 10, 20, 40, 60, 80, 100 ms, 
respectively. Steady state heteronuclear NOE was extracted by calculating peak intensity 
ratios of spectra collected with or without proton saturation of 3 s. The order parameter S
2
 
was calculated with the program relax (29) using the isotropic global rotational diffusion 
model. The global rotational correlation time, τm, was approximated as the average 
rotational correlation times of all structured residues. The residue-specific correlation 
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times (τc) were determined according to the method of Kay et al. (30). Specifically, τc is 
estimated using the equation: τc = 1/(4(πνN) × [6(T1/T2) − 7]
1/2, in which νN is the 
resonance frequency of 
15
N in Hz. DS-induced millisecond time scale conformational 
exchange was measured on a sample containing 300 uM 
15
N-labeled DBPB and 3 mM 
DS dp10 using the CPMG-based relaxation dispersion experiment designed by Tollinger 
et al. (31). The R2 values were extracted by conducting two-point transverse relaxation 
measurements at relaxation delays of 5 and 50 ms. The field strength was varied from 10 
to 210 Hz. The exchange component of the relaxation was estimated as the difference in 
R2 values at field strengths of 10 and 210 Hz. 
4, Structure calculation  
Backbone dihedral angles of well-ordered residues were determined with the 
online server TALOS+ (32). 
13
C- and 
15
N-edited NOESY-HSQC spectra were analyzed 
manually to find unambiguous long-range contacts. The partially assigned peak lists were 
then used as input for CYANA’s automatic structure determination procedure (33). The 
structures and constraint tables generated by CYANA were subsequently used in 
XPLOR-NIH for refinement with RDCs of HN and NC (34). The 10 structures with the 
least NOE violations were shown as the ensemble in the present article. 
5, Gel mobility shift assay 
Heparin and DS fragments were fluorescently labeled with 2-aminoacridone (2-
AMAC) according to the method of Lyon et al. (35). To confirm DBPB-GAG binding 
and size dependency of the interaction, 2 ug of 2-AMAC labeled heparin or DS 
fragments (dp4, dp6, dp8, and dp10) were incubated in 50 mM NaH2PO4 and 150 mM 
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NaCl buffer (pH 6.5) containing 0 or 1 molar equivalent of WT DBPB. Gel mobility shift 
assays (GMSAs) were also carried out to compare the GAG binding affinities between 
DBPB and DBPA and between different mutants of DBPB. In these GMSAs, 1.5 ug of 2-
AMAC heparin dp6 or DS dp10 was treated with 0, 0.5, and 1 molar equivalent of 
proteins. For all GMSAs, the mixtures were incubated at room temperature for 30 min 
and subjected to electrophoresis at 120 V for 15-25 min in 1% agarose gels made with 10 
mM Tris-HCl, 1mM EDTA buffer (pH 6.4). 
6, Affinity assay with immobilized GAGs   
To compare the affinities of WT and mutant DBPBs for native GAGs, ELISA 
assays were performed with biotinylated heparin and DS immobilized on the neutravidin 
coated microwell plates (G-Biosciences). To prepare biotinylated GAGs, 550 ul reaction 
mixtures containing 1 mg of heparin or DS, 0.6 mM biotin, 2.5 mM EDC, 0.1 mM NHS 
and 100 mM MES (pH 5.5) were incubated overnight at room temperature and buffer 
exchanged to remove excess labels. For the ELISA, 2 ug of biotinylated heparin or DS 
was immobilized in each neutravidin well and probed with 2 ug of His-tagged WT DBPA, 
WT DBPB or mutant DBPBs. His-tagged ubiquitin was used as negative control. To 
detect bindings on all ELISA assay plates, anti-HIS antibodies conjugated to horseradish 
peroxidase (HRP) from Qiagen were added. The assays were developed using 
tetramethylbenzidine (TMB) as the substrate and then quenched with 100 uL of 0.1 M 
HCl. Each ELISA was performed at least twice, and four replicates of each sample were 
analyzed to calculate average and standard deviation. 
7, Titrations of DBPs with GAG fragments 
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For WT and mutant DBPBs titrations, aliquots of 5 mM heparin dp10 were added 
to 400 uL of 50 mM NaH2PO4 and 150 mM NaCl buffer (pH 6.5) containing 100 uM 
protein to reach final concentrations of 0.2, 0.6, 1.0, 1.4, 1.8, and 2.2 mM. A 
1
H-
15
N 
HSQC spectrum was collected at each titration point. Chemical shift changes in 
1
H and 
15N dimensions were combined to a single chemical shift value δ (36) using the equation 
δ = [ΔδH
2
 + (2ΔδN)
2
]
1/2, with ΔδH and ΔδN representing the respective chemical shift 
changes in Hz on 
1
H and 
15
N dimensions. The Kds were determined using the 1:1 binding 
model in the software xcrvfit (http://www.bionmr.ualberta.ca/bds/software/xcrvfit/), 
which takes into consideration ligand depletion during the titration. Titrations of WT 
DBPB with heparin dp6 and DS dp10 were performed under the same conditions.  
 
Figure 2.1 Solution Structures of DBPB. 
(A) Ensemble of the 10 lowest-energy DBPB structures. Helix 1, consisting of 
residues 34 to 54, is colored green. Helix 2, consisting of residues 74 to 103, is 
colored blue. Helix 3, consisting of residues 108 to 128, is colored red. Helix 4, 
consisting of residues 133 to 143, is colored cyan. Helix 5, consisting of residues 150 
to 171, is colored purple. The topology of DBPB is shown at the bottom left. (B) 
Ribbon depiction of a representative DBPB structure. 
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2.4 Results 
1, DBPB Structure 
In this study, the structure of DBPB was determined using solution NMR methods. 
The ensemble of 10 DBPB structures most consistent with the experimental data is 
depicted in Figure 2.1. Table 2.1 shows the structural statistics for the ensemble. In 
agreement with the previous predictions, the solution structure of DBPB adopts a 
conformation very similar to the known DBPA structures (10,18). Specifically, DBPB 
consists of five helices as well as two flexible segments arranged similarly as DBPA. 
This topology brings the linker (residues 55-73) between helices one and two and the C-
terminal tail in proximity. Extensive hydrophobic contacts between residues in helices 
two, three and five have been identified in NOESY, leading to the formation of the 
hydrophobic core that establishes the tertiary fold of the protein. Hydrogen/deuterium 
exchange experiments were also performed to measure the stability of the helices. Not 
surprisingly, backbone amide protons of residues in helices two, three and five showed 
the least hydrogen / deuterium exchange (data not shown), indicating the three helices are 
the most stable helices in the protein, consistent with their participation in the 
hydrophobic core.  
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Despite these similarities, DBPB differs from DBPA structurally in several 
respects. Figure 2.2 shows the sequence alignment of DBPA and DBPB from strain B31 
 
Figure 2.2 Sequence Alignment of B31 DBPA and B31 DBPB.  
Lipidation signals of the proteins are not shown. Secondary structures are labeled 
with helices in black boxes. K82, K163 and K170 are colored green in DBPA. K65 
and K69 are colored red, while conserved K81 and K169 are colored green in 
DBPB. 
 
 
Figure 2.3 Superimposition of B31 DBPA and B31 DBPB Structures.  
Ribbon representation of DBPA (pdb: 2lqu) is shown in gold and ribbon 
representation of DBPB is shown in cyan. 
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of B. burgdorferi and positions of the helices in these proteins. The alignment reveals that 
secondary structural elements are well conserved between the two. However, the helical 
content of DBPB is lower than DBPA because helices one and five in DBPB are shorter 
than those in DBPA. Figure 2.3 is the superimposition of DBPA and DBPB structures. 
The helices of the two structures superimpose with a backbone RMSD of 2.0 Å. The 
superimposition shows that the positions of the helices are also conserved between the 
proteins, but shortening of helix five has resulted in a longer unstructured C-terminus in 
DBPB. Moreover, cysteines in the C-terminal tail and helix five of DBPA form a 
disulfide bond that restrains the C-terminal tail to DBPA’s core domain and reduces the 
tail’s flexibility. However, such an intramolecular disulfide bond is missing in DBPB’s 
C-terminus. Backbone dynamics experiments described below suggest the C-terminus as 
well as the linker between helices one and two are indeed very flexible. Another notable 
difference between B31 DBPA and DBPB is the lack of BXBB motif in the linker of 
DBPB. The BXBB motif in the linker has been shown to be an important GAG-binding 
site for GAGs in B31 DBPA(19). The lack of a similar sequence in DBPB means the 
linker of DBPB may not play a role in GAG binding. 
Because GAG-protein interactions are dominated by electrostatic attractions, 
electrostatic potential on the surface of the protein is predictive of possible GAG-binding 
sites. Figure 2.4 is the electrostatic potential map of DBPB. To avoid artifacts produced 
by the artificial cavity formed when the flexible segments are placed near the binding 
pocket, we removed the C-terminus and the linker between helices one and two and only 
calculated the electrostatic potential map of the core domains. A large basic patch can be 
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seen in a pocket composed of helices two and five. A similar patch has also been 
observed in DBPA and was shown to be important in GAG binding (10,37). In agreement 
with the observation, the basic patch in DBPB includes residues K81 and K169, which 
are equivalent to two of the three GAG-binding residues identified in DBPA (Figure 2.2) 
(37).  
 
Figure 2.4 Electrostatic Potential Surface Map of DBPB.  
Calculation of the surface electrostatic potential was carried out without the flexible 
linker and the C-terminal tail. (A) DBPB is in the same orientation as Figure 2.1B. 
(B) DBPB is rotated by 90 degrees about the vertical axis. R78, K81 and K169 are 
outlined. 
 
2, Interactions of DBPB with GAGs 
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WT DBPB was analyzed in a series of experiments to characterize its GAG-
binding properties. A qualitative examination using GMSA was carried out with WT 
DBPB and GAG fragments of defined sizes. In particular, fluorescently labeled heparin 
and DS tetrasaccharide (dp4), hexasaccharide (dp6), octasaccharide (dp8) and 
decasaccharide (dp10) were run on 1% agarose gel with or without DBPB. As shown in 
Figure 2.5, DBPB shifted a larger fraction of heparin fragments than DS fragments, 
indicating that DBPB binds heparin more strongly than DS. This is not unexpected 
considering the highly sulfated nature of heparin. The observations are also in line with 
previous studies using native long GAG chains, in which heparin was shown to be more 
effective in inhibiting bacterial adhesion than DS (14,15). 
 
Figure 2.5 Gel Mobility Shift Assay Evaluation of WT DBPB’s Interactions with 
Heparin and DS. 
 
To obtain more quantitative affinity estimates, we also carried out NMR-
monitored titrations of DBPB using heparin and DS. As is often the case with GAG-
binding proteins, long GAG chains induce protein oligomerization and lead to NMR 
signal broadening without revealing useful information on the GAG-binding residues. As 
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a result, heparin dp10 and DS dp10 fragments were used in NMR analysis of DBPB-
GAG interactions. Figure 2.6A shows 
1
H-
15
N HSQC spectra of DBPB titrated with 
heparin dp10 and Figure 2S1 shows the 
1
H-
15
N HSQC spectra of DBPB titrated with DS 
dp10. The amide proton and nitrogen chemical shift changes induced by both ligands are 
small compared to those seen in B31 DBPA (10). Small chemical shift changes have 
been conventionally associated with multiple binding modes in protein-ligand 
interactions, which can reduce magnitudes of chemical shift changes as a result of 
chemical shift averaging between different binding conformations. Observations of these 
small chemical shift changes indicate DBPB-GAG interactions are less specific than 
DBPA-GAG interactions.  
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Figure 2.6 DBPB Titration with Heparin dp10.  
(A) 
1
H-
15
N HSQC overlays of WT B31 DBPB with increasing concentrations of 
heparin dp10. Signals with large migrations are labeled with their residue numbers 
and arrows to indicate migration directions. T71, S72, E173, N174, K182, K184, 
K185 and K186 have the largest migration. Contours are color-coded with 
increasing concentrations of heparin dp10 (0, 0.2, 0.6, 1.0, 1.4, 1.8 and 2.2 mM). (B) 
Binding curves of DBPB residues S72 and K185 when titrated with heparin dp10. 
(C) Residue specific heparin-induced chemical shift changes. Normalized chemical 
shift perturbations to backbone amide nitrogen and proton by heparin dp10 are 
displayed. (D) Ribbon conformer of DBPB in the same orientation as in Figure 2.4B 
with residues showing large perturbations colored blue. 
 
Using chemical shift changes from several residues that showed large 
perturbations, the dissociation constants (Kd) of the interaction were calculated for the 
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titrations and the binding curves are shown in Figure 2.6 and Figure 2S1. The Kd of WT 
DBPB with heparin dp10 is in the 0.5 mM range. On the other hand, DS dp10 showed no 
sign of saturating the protein even at very high concentrations (Figure 2S1). This 
indicates DBPB’s affinity for DS is weaker than heparin, which is consistent with the 
GMSA data. DS dp10 did induce broadening of many signals in the HSQC spectrum, 
suggesting that both affinity and kinetics of the interactions are different compared to 
heparin dp10. To confirm that signal broadening is the result of dynamic DBPB-DS 
interactions, we prepared a DBPB sample containing 10 molar equivalents of DS dp10 
and measured the contribution of conformational exchange to transverse relaxation of 
amide nitrogen using CPMG-based NMR relaxation dispersion experiments (31). The 
result of the CPMG experiments showed that most DS-induced relaxation dispersion can 
be refocused with a refocusing field strength less than 200 Hz, indicating interactions 
with DS occur on millisecond time scale. Moreover, the two residues that showed the 
strongest exchange relaxation are both located on the linker (G55 and T66) near the 
binding pocket (Figure 2S2). This is consistent with the hypothesis that signal broadening 
was induced by DS binding to the protein. 
Because ligand-induced chemical shift perturbations can indicate the location of 
binding sites, we systematically tabulated heparin-induced chemical shift changes of 
backbone amide nitrogen and hydrogen for DBPB residues. Figure 2.6C shows 
1
H-
15
N 
chemical shift changes on a residue specific basis. The most perturbed residues were T71, 
S72, E173, N174, K182, K184, K185 and K186, most of which are located in the linker 
between helices one and two as well as the C-terminal tail, implying that those residues 
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could be involved in GAG binding. Some residues showed unexpected signal intensity 
increase whereas the majority of residues had reduced peak intensities due to the dilution 
by heparin dp10 addition. The residues with increased intensities included G63, T66, K69, 
S72, G73, S183, K184, K185 and K186, which are also in the linker and the C-terminal 
tail. The increases in their signal intensities are most likely a result of GAG binding-
induced reduction in the rate of backbone amide proton exchange with solvent. We also 
performed similar titrations of DBPB with heparin dp6 ligands to ensure the observed 
chemical shift patterns are not ligand size and composition dependent. The titration 
shows heparin dp6 ligands induced identical chemical shift change patterns in DBPB as 
heparin dp10 (Figure 2S3), confirming DBPB interacts with heparin dp6 in a similar 
manner as heparin dp10. However, Kd of interaction between DBPB and heparn dp6 was 
twice as large as the Kd of interaction between DBPB and heparin dp10. This is 
consistent with the conventional belief that longer heparin ligands have higher affinity for 
DBPB. Unlike DS, signal broadening induced by heparin was minimal. This indicates 
interactions of heparin dp10 with DBPB fall in the fast exchange regime on the NMR 
time scale. However, because two flexible segments, the linker and the C-terminal tail, 
experienced substantial perturbations in chemical shift values upon binding GAGs, it is 
possible that GAG binding affects the nanosecond time scale motion of the two domains. 
To characterize the possible GAG-induced changes in conformational dynamics, we 
analyzed the dynamics of backbone amide nitrogens of the protein using the Lipari-Szabo 
model-free approach (38,39). This method represents the magnitude of internal rotational 
motions using the order parameter S
2
, whose values can be estimated with longitudinal 
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relaxation rates, transverse relaxation rates and steady state heteronuclear NOE (30). An 
S
2
 of zero represents vigorous local motion while an S
2
 of one represents complete 
rigidity. T1, T2 and 
1
H-
15
N NOE of the backbone amide nitrogen atoms were measured 
and fitted using the program relax (29) to obtain order parameters S
2
 for these atoms. The 
data showed the long linker and the C-terminal tail are highly dynamic (Figure 2S4), but 
no significant change in order parameters was detected even after the addition of 10 
molar equivalents of heparin dp10. These observations show heparin dp10 has no 
significant effects on DBPB’s dynamics. Similar observations were also made for DBPA 
(19,40). Finally, although chemical shift mapping is the most popular technique for 
determining ligand-binding sites, artifacts can occur if protein undergoes significant 
conformation changes after binding the ligand. To unambiguously identify residues that 
are close to bound GAGs, we probed DBPB with DS dp12 ligands functionalized with 
the paramagnetic nitroxide radical TEMPO. The unpaired electron in the paramagnetic 
tag generates heterogeneous magnetic field and induces increased longitudinal and 
transverse relaxation rates of spins in the vicinity. The phenomenon, known as 
paramagnetic relaxation enhancement (PRE), leads to decreases in signal intensities of 
nearby residues in a distance-dependent manner such that atoms close to the 
paramagnetic center suffer greater loss of signal than atoms far away (41). Figure 2.7A 
shows the overlays of 
1
H-
15
N HSQC spectra of a sample containing 0.15 mM WT B31 
DBPB and 1.2 mM paramagnetic DS dp12 before and after the radical was reduced with 
ascorbic acid. The spectra revealed large increases in signal intensities of several residues 
upon the reduction of the radical, indicating that they are close to the paramagnetic center. 
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These residues include L57, E59, G73, G74, Q83, I131, Q158, Q162, and N171. Figure 
2.7B shows the location of these perturbed residues. Similar to the results of chemical 
shift perturbation analysis, most TEMPO-perturbed residues are also found in the linker, 
the C-terminus and the basic patch. This is direct evidence that those regions are involved 
in GAG binding.  
 
Figure 2.7 PRE Perturbation of DBPB by Paramagnetically Labeled DS dp12.  
(A) 
1
H-
15
N HSQC overlays of WT B31 DBPB with 8 molar equivalents of TEMPO-
labeled DS dp12. HSQC spectrum before the radical is reduced is shown in blue. 
HSQC spectrum of the protein after reduction of the radical is shown in red. 
Residues showing prominent PRE perturbations are indicated. They are L57, E59, 
G73, G74, Q83, I131, Q158, Q162 and N171. (B) Ribbon representation of DBPB in 
the same orientation as in Figure 2.4B with TEMPO-perturbed residues colored 
red. 
 
3, Determination of DBPB’s GAG-binding sites through mutagenesis 
The DBPB structure identifies several possible GAG-binding sites. In order to 
study the contributions of these residues to GAG binding, WT and mutant DBPBs 
lacking one of the proposed sites were prepared and their heparin and DS affinities were 
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measured. Previous studies suggested that three lysine residues (K82, K163 and K170) 
are crucial to the binding of DBPA with GAGs (18,42). As shown in Figure 2.2, only two 
of the residues (K81 and K169) are conserved in DBPB. However, DBPB contains an 
additional arginine residue at position 78, which is located on the same face of helix 2 as 
K81 and K169 and able to synergistically participate in GAG binding with these residues. 
Besides these basic amino acids, chemical shift mappings showed that two other lysines, 
K65 and K69 in the long linker of DBPB, experienced large perturbations upon GAG 
binding, implying that these two lysines are potentially critical to DBPB’s GAG binding 
activity. Based on these observations, three mutants, K65S/K69S, R78S/K81S and 
K81S/K169S, were prepared. The fact that DBPB C-terminal tail is rich in lysines and is 
the most perturbed domain in chemical shift mapping implies that the C-terminal tail 
might be crucial to GAG binding. Therefore, mutants lacking the last four residues 
(DBPB21-183) or having them mutated from lysines to serines (
184
SSSS
187
) were also 
prepared.  
 
Figure 2.8 Impact of Mutations on DBPB’s Heparin and DS Affinities Evaluated 
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To evaluate the contributions of the proposed sites to GAG bindings, the GAG 
affinities of the mutants were characterized with NMR-monitored titrations, GMSA and 
ELISA. First, we measured different DBPB mutants’ affinities for intact heparin and DS 
using ELISA assays with immobilized heparin and DS. As shown in Figure 2.8, the 
assays revealed the interactions of all mutants with native GAG chains were severely 
diminished. These results confirm the basic amino acids identified are crucial to GAG 
binding. We also studied the effect of the mutations on DBPB’s interactions with sized-
defined GAG fragments using GMSA and NMR. Results of the GMSA are shown in 
Figure 2.9. In the assay, WT DBPB shifted almost all heparin dp6 fragments. In contrast, 
the two C-terminus mutants failed to shift any GAG fragments while R78S/K81S and 
K81S/K169S mutants
 
induced shifts of only a small fraction of GAGs. K65S/K69S 
induced a significant amount of fragment migration, but the fraction of the shifted 
fragments was still much less than that of the WT DBPB. Similar results were obtained 
using a DS-based GMSA (Figure 2.9). These results are in qualitative agreement with the 
ELISA data, and show K65 and K69 are not as important as other clusters of basic amino 
acids. Quantitative evaluations of binding affinities were also carried out by titrating the 
mutants with heparin dp10 (Figures 2S5 & 2S6). The dissociation constants (Kd) derived 
from the titrations are shown in Table 2.2. The Kds are consistent with the result of 
GMSA in Figure 2.9. Specifically, WT DBPB’s Kd is smaller than all mutants, while the 
Kds of K65S/K69S, R78S/K81S and K81S/K169S mutants all showed varying degrees of 
increase compared to the WT protein. In contrast, two C-terminal mutants, 
184
SSSS
187
 
using Immobilized Heparin or DS ELISA. 
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and DBPB21-183, showed no significant chemical shift migrations, suggesting their GAG 
affinities are severely attenuated (Figures 2S5D and 2S5E). Based on the results, we 
believe that the last four lysine residues are the most important GAG binding site in 
DBPB.  
 
Figure 2.9 GMSA Evaluation of the Effects of Mutations on DBPB’s Heparin and 
DS Affinity. 
 
4, GAG affinity comparisons between DBPA and DBPB 
To determine whether there are differences in GAG affinities of DBPA and 
DBPB, we probed their interactions with intact long chains of heparin and DS using 
ELISA. Our data showed B31 versions of DBPA and DBPB have similar affinities for 
both heparin and DS in ELISA (Figure 2S7A). This shows DBPB can be as important a 
GAG adhesin as DBPA. GMSA assay carried out on B31 DBPA and DBPB using size 
defined heparin dp6 also confirmed the similarities in their GAG affinities (Figure 2S7B).  
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Table 2.1 Structural Statistics for the Ensemble of DBPB Structures. 
 
2.5 Discussion 
In this work, we determined the solution structure of DBPB from strain B31 of B. 
burgdorferi and determined its GAG binding residues. The topology of DBPB is similar 
to that of DBPA. Both have five helices and two unstructured segments (10,18). Despite 
________________________________________________________________________ 
no. of NOE-based distance constraints 
        total                                                                                      1635 
        intra-residue (i=j)                                                                 484 
        sequential (|i-j|=1)                                                                477 
        medium range (1<|i-j|<5)                                                     389 
        long range (|i-j|≥5)                                                               285 
        NOE constraints per restrained residue 
a
                             10.0 
no. of RDCs 
        H-N                                                                                       93 
        N-C                                                                                       91 
no. of dihedral angle constraints                                                  240 
total no. of structures computed                                                   50 
no. of structures used                                                                   10 
constraint violations 
b
 
         no. of distance violations per structure 
                     0.1~0.5 Å                                                                 37 
                      >0.5 Å                                                                     0.9 
         no. of dihedral angle violations per structure 
                      >10°                                                                        0.5 
         no. of RDC violations per structure 
                     >1 Hz                                                                       1.4 
rmsd 
         all backbone atoms                                                              0.7 Å (ordered 
c
) 
         all heavy atoms                                                                    1.2 Å (ordered 
c
) 
 
Ramachandran plot summary from Procheck 
d
 (%) 
         most favored regions                                                            92.4 
         additionally allowed regions                                                7.4 
         generously allowed regions                                                  0.2 
         disallowed regions                                                                0.0 
________________________________________________________________________ 
a
 There are 161 residues with conformational restricting constraints. 
b
 Calculated for all constraints for the given residues, using a sum over r
-6
. 
c
 Residues 34-54, 74-103, 108-128, 134-143, and 150-171. 
d
 Residues 30-57, 67-69, 75-130, 134-144, and 150-170. 
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the similarities, their structures differ in several significant ways. Specifically, the C-
terminal helix of DBPB is shorter than the corresponding helix in DBPA, leading to a far 
longer C-terminal tail that is unrestricted by any disulfide bond. The C-terminus is also 
distinguished from its DBPA counterpart by the large number of lysines found at its end. 
Most results from this study indicate these C-terminal basic residues contribute 
significantly to the GAG affinity of DBPB. In particular, the C-terminal residues (K184, 
K185 and K186) showed the largest changes in chemical shifts when DBPB was titrated 
with heparin dp10 and heparin dp6 (Figures 2.6 and 2S3). Removing the last four 
residues or mutating them to serine also attenuated DBPB’s affinity greatly. All these 
show the C-terminus is an important GAG-binding site in DBPB. Although B31 DBPA 
did have two basic residues close to its C-terminus, previous study indicated that their 
impact on GAG affinity of DBPA was modest (19). We believe the location of these 
basic amino acids (none are located at the very terminus) in DBPA and the presence of 
the disulfide bond in DBPA may have restricted GAG ligands’ access to the C-terminus 
of B31 DBPA. However, DBPA sequence heterogeneity is large, and C-termini of 
DBPAs from strain VS461 of Borrelia afzelii and strain PBr of Borrelia garinii have 
been shown to play a crucial role in their GAG binding activity (13,40), setting the 
precedence for the involvement of C-termini in GAG binding. What is different between 
DBPB and all versions of DBPA studied so far is that the canonical GAG binding site 
made up of basic amino acids from helices 2 and 5 do not appear to contribute as much to 
GAG binding in DBPB as it did in DBPA. This might be because the number of basic 
amino acids in DBPB’s canonical GAG-binding pocket is half that of DBPA. In 
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particular, both K163 and R166 of B31 DBPA do not have equivalent basic residues in 
DBPB. The fact that the BXBB motif found in the linker of B31 DBPA is also missing in 
DBPB means the linker cannot contribute to GAG binding either. This may have further 
accentuated the importance of C-terminus of DBPB in GAG binding. 
Table 2.2 Kd Values of DBPB Interactions with GAG Fragments. 
WT and mutant DBPBs were titrated with heparin dp10 and DS dp10. Kds were calculated 
based on S72 and K185 for DBPBs. 
 
 
The flexible nature of the C-terminus means GAG’s interaction with the C-
terminus most likely lacks precise geometric constraints and multiple binding 
conformations are possible. This is consistent with the PRE-perturbation data, which 
showed the reducing end of the ligand can be located in several locations. It also agrees 
with the smaller heparin-induced chemical shift perturbations observed for DBPB since 
heterogeneity in binding conformation are believed to reduce the magnitudes of chemical 
shift perturbations. 
                                                                   Kd (mM) 
                                      ____________________________________ 
                                                      S72                       K185 
WT                                          0.47 ± 0.03             0.54 ± 0.06 
K65S/K69S                             0.90 ± 0.12             0.88 ± 0.06 
R78S/K81S                             1.04 ± 0.26             1.16 ± 0.18 
K81S/K169S                           1.24 ± 0.35             1.22 ± 0.12                 
184
SSSS
187
                                     ------                       ------ 
DBPB21-183                                    ------                       ------     
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Of the five mutants investigated for their GAG-binding activity, all showed lower 
GAG affinities than WT DBPB. In particular, K65S/K69S, R78S/K81S and K81S/K169S 
mutants exhibited significant decreases in their affinities for both heparin and DS size-
defined ligands, while DBPB21-183 and 
184
SSSS
187
 mutants showed no binding to these 
short GAG fragments. These data indicate that all three clusters play a role in promoting 
GAG binding, but the C-terminus is especially critical. Interestingly, in the ELISA assay, 
the 
184
SSSS
187
 mutant showed slightly higher binding for native GAG polysaccharides 
than the DBPB21-183 mutant. It is possible that serines at the C-terminal tail are capable of 
mediating minor GAG binding through hydrogen bond interactions, while the truncation 
of the C-terminus completely attenuates the interaction. One factor that could have 
enhanced the importance of the C-terminus in GAG binding may be its accessibility to 
ligands. Specifically, although dynamic, the location of linker means it can still pose a 
significant barrier to interactions between GAGs and the basic pocket. The surface 
exposed nature of the C-terminus means it is more likely to interact with GAGs than 
basic residues in the pocket, therefore exerts a strong influence on GAG affinity of the 
protein. In fact, B31 DBPB is not the only DBP with important GAG-binding in its C-
terminus. The C-terminus of DBPA from Borrelia afzelii strain VS461 is also crucial to 
the protein’s GAG affinity (13). Despite its importance in facilitating GAG-binding, the 
C-terminal tail showed no sign of perturbation in the PRE experiment. We believe this is 
possible because only the reducing end of DS dp12 is labeled with TEMPO, and the C-
terminal tail may interact mainly with the non-reducing ends of the GAG fragments, 
allowing it to be unaffected by the paramagnetic tag. 
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CHAPTER 3 
BACKBONE ASSIGNMENT OF INTEGRIN αM I-DOMAIN 
3.1 Abstract 
 Integrin is a family of cell surface receptors that primarily bind extracellular 
matrix (ECM) components, allowing cells to migrate and transform. Consisting of α and 
β subunits, the heterodimers undergo global conformational rearrangements during 
activation that dramatically increase their affinity for their ligands. αMβ2, or Mac-1, has a 
broad ligand recognition spectrum, making it the most promiscuous member of the 
protein family. Recent studies also indicated Mac-1’s ligand binding mechanism is 
unique among integrins. α subunit of Mac-1 contains an α I-domain, which is the primary 
ligand binding site. Crystal structure of αM I-domain reveals a Rossmann fold, common 
to all α I-domains. However, the reason behind αM I-domain’s ability to bind a diverse set 
of ligands is still not clear. We are interested in investigating the ligand-binding 
mechanism of αM I-domain. Present work focuses on NMR backbone assignment and 
biophysical characterizations of αM I-domain, including pH stability, Mg
2+
 bindings and 
homodimeric interactions. 
3.2 Introduction 
Half of the 18 α variants contain α I-domains. In fact, before the whole 
extracellular structure was solved, the structures of individual integrin domains including 
αM I-domain were already determined (1-3). α I-domain, also known as a von Willebrand 
factor A domain, usually contains 200 amino acids. In α I-domain containing integrins, α 
I-domain is the primary ligand binding site. Left panel of Figure 3.1 is the crystal 
42 
 
structure of integrin αM I-domain. Like other α I-domains, αM I-domain adopts a 
Rossmann fold with 6 central β strands surrounded by 7 α helices on the outside (1). α I 
domain is anchored to the β propeller on the bottom surface with N and C linkers. On the 
top surface is an important site known as metal ion dependent adhesion site (MIDAS). 
Many divalent metal ions, such as Ca
2+
, Mg
2+
 and Mn
2+
, bind to MIDAS, with Mg
2+
 
being the physiological cation (5). The divalent cation is coordinated by side chains of 
five residues in MIDAS. They all reside on loops: 1, three residues (Asp, Ser and Ser in a 
conserved motif DXSXS) can be found on the β1-α1 loop; 2, fourth residue (Thr) is 
located on the α3-α4 loop; 3, the last residue (Asp) is on the β4-α5 loop. Metal 
coordinating residues in MIDAS are displayed in the middle panel of Figure 3.1. Other 
than these residues, water molecules also provide coordinating oxygens (4). It has been 
established that MIDAS is important for ligand bindings in the following respects: 1, the 
divalent cation is necessary for ligand binding and acts as the bridge between α I-domains 
and ligands through metal coordination; 2, MIDAS residues that do not coordinate metals 
are also required for ligand recognition (4). Just like the global structural rearrangement 
of integrin, α I-domain also undergoes conformational change upon activation. Upon 
activation, metal coordinating loops in MIDAS rearrange, accompanied by a large shift in 
the β6-α7 loop and the characteristic 10 Å axial movement of α7 helix, creating a 
conformation with high affinity for ligands (open). This α7 helix movement transmits α I-
domain conformational signals to the rest of integrin molecules. Right panel of Figure 3.1 
displays the conformational changes within αM I-domain in close/low affinity and 
open/high affinity states. 
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Integrin αMβ2 (Mac-1 or CD11b/CD18) is the most dominant integrin on myeloid 
cells. Mac-1 is responsible for adhesive activities of leukocytes (6). Although Mac-1 
expression on neutrophils and monocytes is upregulated in response to inflammation 
stimuli, the increase in ligand interactions is largely due to enhanced affinity of a small 
fraction of Mac-1 rather than higher density of Mac-1 on cell surface (7-9). Most of 
ligand activities in Mac-1 are contributed by αM I-domain. What’s unique about Mac-1 is 
its broad ligand binding specificity. The number of reported Mac-1 ligands is over 40 and 
still increasing, making it the most promiscuous member of the integrin family (10). 
Many ligands of Mac-1 are ECM components, such as fibrinogen (11) and complement 
C3 cleavage fragment C3bi (12). The broad ligand range of Mac-1 has led to questions of 
binding motifs recognized by Mac-1. Ugarova et al. showed that Mac-1 has high affinity 
for peptides that contain high proportions of basic amino acids (10). As cationic ligands 
are highly positively charged and often lack acidic residues to coordinate divalent metal 
ions in MIDAS, the classical mechanism of α I-ligand interaction may not apply for 
cationic ligands. Specifically, in the classical Mg
2+
 dependent ligand binding mechanism, 
one coordinating residue in MIDAS must leave and be replaced by an acidic amino acid 
from the ligand. Mg
2+
 serves as the bridge between MIDAS of α I-domains and ligands. 
Given the broad and diverse ligand spectrum of Mac-1, and the fact that many of the 
ligands are free of acidic amino acids, it is possible that Mac-1 recognizes ligands via 
multiple mechanisms.  
The following chapters will explore the ligand binding mechanism and dynamics 
of integrin αM I-domain using solution NMR techniques. Information on ligand binding 
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and conformation change is inferred mostly from changes in 
15
N-edited HSQC spectrum 
of αM I-domain. To correctly interpret the data, bonded 
15
N and 
1
H atoms that give rise to 
the signals in the spectrum must be determined. However, there is currently no NMR 
study of αM I-domain and assignment of these signals has never been done. Therefore, 
this chapter will focus on determining NMR chemical shift assignments of backbone 
atoms in αM I-domain as well as biophysical characterizations of integrin αM I-domain, 
such as Mg
2+
 bindings and pH stability. Our experiments also unexpectedly revealed 
presence of homodimers formed as result of interactions between termini of the protein 
and the MIDAS, which are mitigated only when both termini are shortened. 
 
Figure 3.1 Integrin αM I-domain Structure. 
(Left), ribbon structure of αM I-domain (pdb: 1jlm) with Mn
2+
 in MIDAS. 
Secondary structures are labeled. (Middle), metal coordinating residues in MIDAS 
of closed αM I-domain. (Right), integrin αM I-domain conformations in low and high 
ligand affinity states. Segments with the most significant shift are colored yellow in 
closed/low affinity state (pdb: 1jlm) and cyan in open/high affinity state (pdb: 1ido). 
The rest of αM I-domain is colored grey. 
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3.3 Materials and Methods 
1, Integrin αM I-domain expression and purification  
The open reading frame (ORF) of the wild type/WT (Q119-E333) αM I-domain 
was cloned with His-tagged ubiquitin at 5’ end into the pHUE vector (13). Truncated 
versions were designed as N-truncated (E131-E333), C-truncated (Q119-T324) and N/C-
truncated (E131-T324). The plasmid was transformed into BL21 (DE3) cells for 
expression in M9 medium at 37 °C until an OD600 of 0.8 is reached. 0.5 mM IPTG was 
added into the expression mixture and cultured overnight at room temperature (23°C) 
before harvest next day. M9 medium was isotopically supplemented with 
15
NH4Cl and/or 
13
C glucose.  After harvest, cells were resuspended with lysis buffer (20 mM sodium 
phosphate, 0.5 M Nacl 10 mM imidazole, 5% glycerol, 0.01% NaN3), then treated with 
1mg/mL lysozyme for ~ 25 minutes before sonication. After sonication, mixture was 
centrifuged and supernatant was collected. The supernatant was applied on a 5mL 
HisTrap column (GE Life Sciences) during Ni affinity chromatography. To elute bound 
protein off the column, an imidazole gradient (ranging from 35 to 500 mM) was applied 
at a flow-rate of 3 mL/min. Fractions containing bound αM I  were buffer exchanged to 25 
mM Tris and 100 mM NaCl (pH 8.0) for overnight digestion with USP2 deubiquitinating 
enzyme (1:20 molar ratio) (13). After cleavage, digested αM I-domain was collected on a 
second Ni column. Finally, collected fractions were applied onto a Superdex 75 size 
exclusion column (GE Healthcare Life Sciences, Little Chalfont, UK). Protein purity is 
confirmed on a SDS-PAGE gel. 
2, NMR data acquisition and backbone assignment 
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All NMR data were recorded on Bruker Ultra-Shield 600 MHz and 850 MHz 
spectrometers (Bruker Instruments, Inc., Bellerica, MA, USA), both equipped with cryo-
probes. NMR samples contain ~ 0.15-1 mM protein in 20 mM HEPES and 100 mM NaCl 
(pH 7.0). For backbone assignment, HNCACB, HNCOCACAB, HNCO and HNCACO 
spectra were collected on 
2
H/
13
C/
15
N labeled proteins. HNCA, HNCOCA spectra were 
collected on 
13
C/
15
N samples. To assist assignment, CCCONH and 
15
N-edited NOESY 
spectra were also acquired. All NMR data were processed and analyzed with NMRPipe 
(14) and NMRView (15) respectively. Chemical shift information of Cα, Cβ, and 
backbone HN, N and CO were used in chemical shift index (CSI) analysis using 
developers’ server (http://csi3.wishartlab.com/cgi-bin/index.php) (16). Mg2+ was added in 
series to 150 µM of 
15
N integrin αM I-domain for concentrations ranging from 0 to 50 
mM Mg
2+
. 
3, Paramagnetic relaxation enhancement (PRE) 
G321C mutagenesis was performed on N-truncated (E131-E333) and N&C-
truncated (E131-T324) to introduce cysteine for paramagnetic labeling while C-truncated 
(Q119-T324) has C128 on its N terminus. MTSL, (1-Oxyl-2,2,5,5-tetramethylpyrroline-
3-methyl) methanethiosulfonate (Santa Cruz Biotechnology), was dissolved in DMSO at 
~0.5 M as stock solutions. Before MTSL labeling, 10mM DTT is added to purified αM-I 
domain and then the mixture is applied onto HiTrap Desalting column (GE Life Sciences) 
to remove DTT and obtain free cysteine for high labeling efficiency. 10 molar 
equivalents of MTSL were added to the protein solution and incubated at room 
temperature overnight. The next day, the mixture is then buffer exchanged to remove 
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unreacted free MTSL and then concentrated for NMR studies. 1D 
1
H NMR spectra were 
performed to verify MTSL labeling. 
For PRE experiments, 
1
H-
15
N HSQC spectra (oxidized) were collected for a ~300 
uL sample of 300 µM 
15
N MTSL-labeled αM I domain alone or equal molar (150 µM) 
mixture of 
15N αM I and MTSL-labeled αM I. Ascorbic acid was added in 5:1 molar ratio 
to reduce the paramagnetic radical and another 
1
H-
15
N HSQC spectra (reduced) were 
collected. 
4, Circular dichroism (CD) spectroscopy 
CD spectra were collected on a temperature controlled JASCO J710 
spectropolarimeter. CD measurements were performed for 20 µM αM I domain in 20 mM 
HEPES, 100 mM NaCl at pH levels of 4.0, 5.0, 6.0 and 7.0. CD data were recorded at 
20 °C in the far- UV region (200-250 nM) with 100 mDeg sensitivity, 0.5 nm data pitch 
and scanning speed of 50 nm/min. Another sample containing pH 7.0 buffer only was 
also used as the negative control. 
3.4 Results 
1, Backbone Assignment 
The backbone assignment was made through a combination of three dimensional 
(3D) NMR experiments. Cα and Cβ chemical shift values associated with each signal in 
the 
15
N HSQC spectrum are extremely informative as not only do they provide a way to 
connect consecutive residues but they also help in narrowing down amino acid types. 
Therefore, HNCACB and HNCOCACB spectra were acquired for 
2
H,
13
C,
15
N-labeled αM 
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I-domain, together with HNCO and HNCACO spectra. Figure 3.2A and B show 
HNCACB, HNCOCACB, HNCO, HNCACO spectra of D273, A274 and F275. Cβ of 
A274 is a methyl carbon therefore its value is usually below 20 ppm. G272 has no Cβ 
and its Cα value is normally close to 45 ppm. By matching Cα and Cβ chemical shifts of 
signals from both HNCACB and HNCOCACB, we were able to assign over 70 % of 
residues in αM I-domain. However, a number of residues were not assigned, mostly in β 
strand regions. The missing assignments are most likely due to weak signals. In particular, 
careful examination of 
1
H-
15
N heteronuclear single quantum coherence (HSQC) spectra 
of 
2
H,
13
C,
15
N-labeled and 
15
N-labeled protein samples revealed that a number of peaks 
are missing or considerably weaker in the deuterated sample compared to the 
undeuterated sample (Figure 3.4). This means that some backbone amide deuterons have 
slow exchange with solvent water, therefore is not observable in the 
15
N HSQC spectrum. 
To overcome the hurdle, undeuterated 
13
C,
15
N-labeled αM I-domain was prepared. HNCA 
and HNCOCA were recorded because they provide Cα information with higher 
sensitivity, which assist assignment when HNCACB and HNCOCACB of the deuterated 
sample do not yield satisfactory data quality. Figure 3.2C shows HNCA and HNCOCA 
spectra of residues in β4 strand. Signals of those residues were not observed in NMR 
spectra of deuterated samples. 
So far, around 90% of observable backbone H-N peaks were assigned. Figure 3.3 
displays 
15N HSQC spectra of αM I-domain (E131-T324). Assigned peaks are marked 
with amino acid types and residue numbers. Unassigned residues are concentrated in two 
segments, α3-α4 loop and α4 helix. This is likely to be a result of the inherent dynamics 
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of the protein, which causes line broadening of signals. Chapter 5 will explore the 
dynamics of integrin αM I-domain using relaxation dispersion experiments. To predict 
secondary structure of current αM I domain, Cα, Cβ, and backbone CO, HN and N 
chemical shifts were combined as inputs for chemical shift index (CSI) analysis (16). The 
result, shown in the lower panel of Figure 3.3, suggests that the construct used here 
displays a pattern characterized by interleaved β strands and α helices, known as 
Rossmann fold (1). The secondary structure organization is consistent with the crystal 
structure of αM I-domain (pdb: 1jlm) (17). Therefore, the protein should adopt a similar 
structure in solution. 
Hydrogen/deuterium exchange is also useful in providing insights into protein 
structures. Figure 3.4 illustrates overlays of 
1
H-
15
N HSQC spectra of 
15
N-labeled and 
2
H,
13
C,
15
N-labeled αM I-domain. Residues whose amide hydrogens are protected from 
solvent exchange are also mapped onto the ribbon structure. When comparing the spectra, 
it was instantly noticed that some peaks are only observed or have considerably higher 
signal intensities in undeuterated samples. This implies that these residues are protected 
from exchange with solvent hydrogen due to intramolecular hydrogen bond network 
or/and lack of solvent exposure. The protected residues are primarily located in β1, β2, β4, 
and β5 strands. The position of protected residues is consistent with the structure of αM I-
domain in which the central β strands are surrounded and shielded from solvent by 
surrounding α helices (17). 
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Figure 3.2 3D NMR Spectra for Backbone Assignment of αM I-domain. 
(A), HNCACB and HNCOCACB spectra for F275, A274 and D273 in β5-α6 loop. 
(B), HNCO and HNCACO spectra for F275, A274 and D273 in β5-α6 loop; (C), 
HNCA and HNCOCA spectra of V239, V238 and L237 in β4 strand. 
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Figure 3.3 Backbone Assignment of Integrin αM I-domain.  
Upper panel: 
1
H-
15N HSQC spectra of integrin αM I-domain (E131-T324). The over-
crowded region is enlarged for better presentation of peaks and assignments. 
Middle panel: unassigned residues are colored blue in αM I-domain ribbon structure 
(pdb: 1jlm). Lower panel: Chemical shift index (CSI) analysis. CSI-predicted 
secondary structures are plotted (green) above secondary structures (black) of the 
αM I-domain crystal structure (pdb: 1jlm). Positions of α helices (rectangle boxes) 
and β strands (pentagon boxes) are labeled with residue numbers. 
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In the initial process of backbone assignment, several peaks were found to possess 
similar Cα and Cβ chemical shift values. The CCCONH spectrum indicates that these 
peaks also share similar chemical shift values for other side chain carbon atoms. 
CCCONH not only reveals amino acid type but also provides definitive proof that some 
of these signals represent two states of the same residue. These residues with double 
resonances are all located in the N terminus: K120, E123, A124 and G127. The 
appearance of two distinct populations that are well resolved in NMR spectra is 
characteristic of chemical exchange on slow timescales (18). However, such dynamics 
was not observed for C-terminal residues or residues close to other prolines. The reason 
for the resonance doubling at the N-terminus is revealed by the CCCONH spectra of 
residue P122 as shown in Figure 3.5. The two states of P122 have very distinctive 
chemical shift patterns that represent cis- and trans- isomers of the proline. The trans-
isomer has higher signal intensity than the cis-isomer, in all 2D and 3D NMR spectra, 
suggesting a biased trans-isomer population. The “double-state” residues (K120, E123, 
A124 and G127) are located around P122 and also display unequal signal intensities, 
indicating that they are the results of P122 isomerization. Such proline isomerization on 
the slow timescales has been reported before in protein NMR studies (19,20). To our best 
knowledge, this is the first report of proline isomerization in integrin α I-domains. The 
lack of proline could explain why this slow dynamics is not present in the C terminus.  
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Figure 3.4 Central β Strands are Protected from Exchange with Solvent.  
(A), 
15
N HSQC overlays of residues with lower signal intensity. (B), protected 
residues are mapped (colored red) on the ribbon structure of αM I domain. 
 
2, pH stability and Mg
2+
 titrations 
Like other membrane proteins, integrins are present on cell surface and regulated 
by the dynamic environment in which the cells reside. It has been found that lower 
extracellular pH, which occurs naturally at sites of inflammation, promotes integrin 
activation by facilitating open conformations and up-regulates many physiological 
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processes mediated through integrins, such as cell adhesion and migration (21,22). 
Present study focus on integrin αM I-domain and assess its pH stability with circular 
dichroism (CD) spectroscopy. αM I-domain samples in buffers ranging from pH 4.0-7.0 
and a control sample without proteins were analyzed with CD. The CD data revealed that 
the overall fold of αM I-domain is relatively stable under acidic conditions, even as low as 
pH 4.0 (Figure 3.6). This naturally leads to questions of how pH affects the conformation 
of the entire integrin molecules when α I-domain structure is not significantly altered. As 
shown through molecular dynamics simulations, acidic pH favors headpiece opening in 
some integrins (21). Therefore, it would be insightful to investigate how αM I-domain 
responds to lower pH levels. 
 
Figure 3.5 CCCONH spectra of Two Peaks Representing E123. 
The side chain carbon resonances are from the previous residue P122. Left and 
right spectra are for trans- and cis-isomers respectively. 
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Divalent metal ions, such as Mg
2+
, Mn
2+
 and Ca
2+
, are critical for integrins as they 
are capable of regulating the ligand binding affinities (5). It was found that Mn
2+
 
promotes, while Ca
2+
 inhibits integrin activation in many instances (23-25). Under 
physiological conditions, α I-domain MIDAS binds Mg2+ (5). Three MIDAS loops 
donate residues to directly coordinate Mg
2+
. In the ligand-bound form, MIDAS 
rearranges so that one coordinating residues leaves and is replaced by an acidic residue 
from the ligand, thereby making Mg
2+
 necessary for ligand bindings (4). This is 
corroborated by X-ray crystal structures of high-affinity/open and low-affinity/closed 
states of integrin αM I-domains (1,17). In light of the importance of metal bindings, the 
present work also assesses how pH affects Mg
2+
 bindings using solution NMR techniques. 
Figure 3.7 displays HSQC overlays of 
15N αM I-domain in the presence or absence of 
Mg
2+
 at pH 5.0 and 7.0. At pH 7.0, Mg
2+
 addition results in a significant number of peak 
migrations, indicative of Mg
2+
 bindings. While at pH 5.0, there is no peak migration, 
which means Mg
2+
 bindings are not present under acidic pH conditions. Lower pH 
protonates acidic amino acids, therefore discourages metal coordination. 
 To quantify Kd of Mg
2+
 bindings at pH 7.0, Mg
2+
 was added in series to αM I-
domain sample to reach each specific concentration (0, 0.25, 0.5, 1.0, 2.0, 5.0, 10 and 50 
mM). 
15
N HSQC spectrum was collected for each titration point and displayed together. 
Instantly, it was noticed that Mg
2+
 bindings fall into a slow timescale exchange regime as 
two resolvable peaks were observed. With Mg
2+
 concertation increasing, one resonance 
gradually decreases in intensity while the other gains in intensity. Using the line shape 
fitting approach developed by Kovrigin (26) , two residues were selected and fitted to 
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extract the Kd value. Kd is fitted to be ~1.3 ± 0.3 mM, consistent with previous results 
from isothermal titration calorimetry (27). However, the NMR study also revealed that 
the kinetics of interaction between the protein and metal is slow. Specifically, the 
dissociation rate constant is only 0.0015 s
-1
. Figure 3.8 shows line shape analysis of G141 
and F184 in Mg
2+
 Titration.  
 
Figure 3.6 CD Spectra of Integrin αM I-domain at Different pH Levels.  
20 uM αM I-domain in 20 mM HEPES and 100 mM NaCl under pH ranging from 
4.0 to 7.0. HEPES buffer pH 7.0 serves as the negative control. 
 
Figure 3.7 Mg
2+
 Bindings under Different pH Conditions. 
The left (pH 7.0) and right (pH 5.0) are 
1
H-
15
N HSQC spectra are 150 µM 
15N αM I 
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3, Homodimeric interactions 
domain (Q119-E333) with or without 4 mM Mg
2+
. 
 
Figure 3.8 Line Shape Fitting Analysis of αM I-domain Titration with Mg
2+
.  
Mg
2+
 concentrations are colored coded, ranging from 0 to 50 mM. 1D traces of G141 
and F184 are displayed with error bars representing noise r.m.s. deviation for each 
spectrum. Data were fitted according to a two state model and the best fits are the 
curves with no error bars. Kd is fitted to be 1.3 ± 0.3 mM. 
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As shown in the X-ray structure of integrin αxβ2, the interface of the heterodimer 
involves α I-domain and β propeller from α subunit and β I-domain from β subunit (28). 
To be more specific, N and C termini of α I-domain are in close proximity to the MIDAS 
of β I-domain. The proposed activation mechanism (Figure 1.4 in Chapter 1) also denotes 
that an acidic amino acid on the C terminus of α I-domain interacts with MIDAS of β I-
domain upon activation. Because the structural similarity between α I-domains and β I-
domains, this raise the question of whether α I-domains have the potential of self-
association. In this work, we examined homodimeric interactions between αM I-domains 
using paramagnetic relaxation effects. Paramagnetic relaxation enhancement (PRE) in 
NMR is widely used to provide intermolecular distance-related information, which will 
be explored in details in the next chapter. We utilized the only cysteine in the protein, 
C128 on N terminus, to attach the paramagnetic nitroxide radical MTSL (S-(1-oxyl-
2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate) in full 
length (Q119-E333) version of integrin αM I-domain. The magnetic field produced by 
unpaired electron of the radical will perturb nearby atoms and consequently increase 
these atoms’ transverse relaxation rates (R2) in a distance dependent fashion and therefore, 
lower signal intensity. Ascorbic acid can be added to reduce paramagnetic radicals and 
signal intensity is restored. The signal loss is inversely correlated with the distance 
between the radical and the atom (29).  
We first observed homodimeric interactions on MTSL-labeled integrin αM I-
domain as displayed in Figure 3.9. Not surprisingly, N-terminal (C128) MTSL perturbs a 
great number of residues in the nearby N/C termini region, such as G321 (C terminus), 
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D134 (N terminus) and I265 (α5-β5 loop). Unexpectedly, residues Q204, G207 and R208 
on α3- α4 loop in MIDAS are also perturbed by the N-terminal MTSL (Figure 3.9A). 
PRE analysis using a mixture of natural abundance MTSL-αM I and 
15N αM I-domain 
confirmed that PRE perturbations on MIDAS residues are indeed intermolecular rather 
than intramolecular (Figure 3.9B). 
 
Figure 3.9 Homodimeric Interactions of Integrin αM I-domain.  
(A), 
15
N HSQC spectra of MTSL-tagged 
15N αM I-domain. Residues are perturbed 
by MTSL-labeled N terminus (C128). The upper panels are G207, R208 & Q204 in 
MIDAS, while the lower panels are G321, D134 and I265 in N/C termini region. (B), 
15
N HSQC spectra of 
15N αM I-domain mixed with natural abundance MTSL-tagged 
αM I-domain (C128). 
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Now the intermolecular interaction of αM I-domains is established. To identify 
which terminus is responsible for facilitating homodimeric interactions, the following 
constructs were designed, N-truncated version (E131-E333, C321-MTSL), C-truncated 
version (Q119-T324, C128-MTSL) and N&C-truncated (E131-T324, C321-MTSL). PRE 
data were acquired in the same way as described in Figure 3.10. For the three constructs 
above, significant perturbation is observed on residues in the N/C termini region (data not 
shown), which is not surprising as MTSL is tagged on either N or C terminus. However, 
as shown in Figure 3.10, several residues in the MIDAS, such as Q204 and G207, have 
enormous signal loss in either N-truncated or C-truncated versions whereas minor signal 
 
Figure 3.10 N or C Terminus Alone Mediates Intramolecular Homodimeric 
Interactions of Integrin αM I domain.  
N (C321-MTSL), C (C128-MTSL) and N/C (C321-MTSL)-truncated versions are 
generated. C128 and C321 are on N terminus and C terminus respectively. N/C 
MTSL perturbations to G207 and Q204 are significant in N-truncated or C-
truncated versions. Only when N and C termini are simultaneously removed are the 
intramolecular interactions abolished. 200 µM of MTSL-tagged 
15
N-integrin αM I 
domain. 
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decrease is seen on N&C-truncated version. Removal of N-terminus or C-terminus alone 
cannot abolish this intramolecular interaction to the same level as simultaneous removal 
of N and C termini. Therefore, N or C terminus alone is capable of interacting with 
MIDAS of another αM I-domain. To our best knowledge, this is the first report of 
intermolecular interactions of integrin α I-domain. 
3.5 Discussion 
 NMR has been instrumental in determining structures of integrin transmembrane 
and cytoplasmic domains (30-36). There have also been reports on use of NMR in 
studying integrin α1 I (37-39), α2 I (40) and αL I (41-44) -domains. To our best knowledge, 
this is the first NMR study of αM I-domain. Interestingly, although αM I-domain and αL I-
domain share considerable sequence and structural homology, 
15N HSQC spectrum of αM 
I-domain was of significantly worse quality compared to that of αL I-domain. In 
particular, signals in 
15N HSQC of αL I-domain showed far greater chemical shift 
dispersion and signal intensities are more even (44). The uneven signal levels in αM I-
domain spectra could be the result of oligomerization or dynamics. T2 relaxation 
experiments provided estimations of rotational correlation time (τc), which does not 
imply presence of dimer, or any other oligomer. TROSY (transverse relaxation optimized 
spectroscopy)-HSQC did not show any significant improvement in resolution and 
sensitivity, which also suggests lack of oligomerization. Therefore, the uneven signal 
intensity distribution is likely a result of the intrinsic dynamics of the protein. In addition 
to that, most of the unassigned residues are in the α3-α4 loop and α4 helix. As almost all 
observed peaks are assigned, unassigned residues are due to weak signals. This hints the 
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occurrence of conformational dynamics, which leads to signal broadening. Poor NMR 
data quality because of dynamics might suggest why there is no NMR study on αM I-
domain, despite being well studied previously by crystallography (1,17,45). Chapter 5 
will explore the conformational dynamics using NMR relaxation dispersion experiments.  
CSI analysis performed in this study indicates that the construct used here adopts 
the same secondary structural arrangement in solution as the crystal structure, indicating 
they have the same conformation (17). When deuterated αM I-domain was first prepared, 
many peaks in its 
1
H-
15
N HSQC spectrum are missing or have significantly lower signal 
intensities compared to undeutrated samples. The signal loss is due to restricted 
hydrogen/deuterium exchange because of the extensive hydrogen bond network. These 
protected residues are located in the central β strands sandwiched by α helices, which is 
consistent with the crystal structure. 
Proline isomerization was reported to act as molecular switches that control 
protein activation (20). This type of activation is very unique as it does not require 
covalent modification and is able to induce significant conformational changes because 
the cis and trans isomers have drastically different dihedral angles. αM I-domain has 
shown well resolved signals in NMR spectra, supporting the existence of proline 
isomerization with “trans” as the major state.  Pro 122 on the N-terminal linker is close to 
the interface of α I-domain, β-propeller and β I-domain. Studies have shown that 
mutations in the interface and antagonists for the interface both promote integrin 
activation (46,47). Therefore it begs the question of whether P122 isomerization could 
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regulate integrin activation by modulating conformations in the interface. How P122 
isomerization is biologically relevant should be investigated further. 
Another potential activation factor is pH. Molecular dynamics (MD) simulations 
indicated that lower pH levels facilitate integrin activation by promoting headpiece 
opening (21). CD spectroscopy revealed that integrin αM I domain is very resistant to pH 
change and maintains its fold even at pH 4.0. In contrast, αM I-domain variants designed 
to adopt the active state through truncation at I316 or bearing the I316G mutation (48), is 
far less resistant to pH (data not shown). It is not known if the dramatic difference in pH 
tolerance between inactive and active states is functional or relevant under physiological 
conditions. 
Universal to all integrin molecules, Mg
2+
 bindings are important to ligand 
interactions. Mg
2+
 titrations under pH 5.0 and pH 7.0 suggest that lower pH levels abolish 
Mg
2+
 bindings. At pH 7.0, two populations for apo and Mg
2+
 bound states respectively 
are well resolved in NMR spectra, suggesting chemical exchange on slow timescales. 
Quantitative analysis using line shape fitting approach reveals the Kd is ~ 1.3 ± 0.3 mM 
range at pH 7.0 (26). This is in agreement with Kds determined from isothermal titration 
calorimetry (ITC) (27). Weak metal affinity indicates that αM I-domain is basically not 
saturated under physiological conditions (1 mM Mg
2+
). As Mac-1 is the most 
promiscuous of all integrins, various ligands might interact with αM I-domain through 
different mechanisms. 
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Surprisingly, homodimeric interactions between integrin αM I-domains were 
discovered in current studies. Specifically, MIDAS of one αM I-domain weakly interacts 
with N/C termini of another αM I-domain. In light of the similarity between α I- and β I- 
domains, such homodimeric interactions of αI domains are suspected to be reminiscent of 
the heterodimeric interaction of α I- and β I-domains. The intermolecular interaction 
resembles the interface in intact integrin proteins where α chain and β chain lie together. 
Crystal structure of αxβ2 confirms the structural arrangements (28). Not surprisingly, 
intramolecular PRE effects are more significant than intermolecular PRE. However, 
intermolecular PRE perturbations are still present, especially for Q204, G207 and R208 
on the α3-α4 loop. Since N and C terminus are positioned closely together, it was 
intuitive to investigate which terminus is involved in the intermolecular interactions. As 
revealed in Figure 3.10, intermolecular PRE perturbations on α3-α4 loops in MIDAS are 
still observed after only one of the termini is removed, while they are obviously abated 
when N and C termini are simultaneously truncated. This clearly elucidates that either 
terminus is able to mediate the homodimeric interactions. However, a lot of questions 
remain unanswered. For example, what is the biological relevance of the interaction and 
how is it regulated (pH or Mg
2+
)? More work needs to be performed to answer the 
questions. 
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CHAPTER 4 
A NOVEL MECHANISM GOVERNS INTERACTIONS OF αM I-DOMAIN WITH 
CATIONIC LIGANDS 
4.1 Abstract 
 αMβ2 (Mac-1, CR3, CD11b/CD18) is an α I-domain containing member of the 
integrin family. It is highly expressed in macrophages and plays important roles in many 
immunological events. Unlike other integrins, Mac-1 can bind a broad spectrum of 
ligands. Studies have shown that αM I-domain, which is responsible for more than 90 % 
of ligand binding activity of Mac-1, prefers ligands enriched in basic amino acids, not 
acidic amino acids. This contradicts the canonical ligand binding mechanism of α I-
domains, which requires an acidic amino acid in the ligand to facilitate metal mediated 
binding to the domain. Lack of acidic amino acids in these ligands hints the existence of a 
novel ligand binding mechanism for αM I-domain. In the present study, we analyzed 
interactions of αM I-domain with two of its cationic ligands using solution NMR and 
microscale thermophoresis (MST). Our data indicate that αM I-domain bind these ligands 
in a metal-independent manner and the binding site is located near αM I-domain’s metal 
ion dependent adhesion site (MIDAS). We believe this is made possible by the weak 
metal affinity of αM I-domain’s MIDAS, which leaves it metal-free under physiological 
conditions, allowing acidic amino acids in MIDAS to interact with positively charged 
ligands. Consistent with this is the observation that high concentrations of divalent 
cations have inhibitory effect on binding of the cationic ligands and one cationic ligand, 
the chemokine PF4, actually prevents binding of divalent cations to MIDAS. We also 
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determined that the binding of PF4 does not change the conformation of αM I-domain. 
This implies activation of Mac-1 by these ligands should be a consequence of ligand 
induced integrin clustering. 
4.2 Introduction 
 αM β2 (Mac-1, CR3, CD11b/CD18) is a member of the integrin receptor family 
highly expressed in macrophages and neutrophils. Its function is vital to a number of 
important immunological activities but is especially crucial to opsonization and 
trafficking of macrophages and neutrophils. Integrins are heterodimeric protein 
complexes made up of an α and a β subunit. They act as adhesion receptors that connect 
intracellular structures with the extracellular environment. Because of their importance, 
activities of integrins are closely regulated. In particular, integrins in the inactive form 
have lower affinity for their ligands than integrins in the active form. Conversion of 
inactive integrins into the active form can be triggered by intracellular as well as 
extracellular signals. These pathways are referred to as inside-out or outside-in pathways 
depending on the origin of the signal. The mechanism of inside-out pathways is relatively 
well understood. Specifically, activation of certain intracellular kinases is believed to lead 
to phosphorylation of cytoplasmic domains of the α and β subunits as well as recruitment 
of cytoskeletal proteins such as talin to the integrin, causing the cytoplasmic domains to 
separate and the ectodomains to change from a folded to extended conformation. The 
consequence of these changes is an increase in the integrin’s affinity for its ligands (1). 
The exact mechanism of outside-in signaling is less well understood, but it is accepted 
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that binding of some ligands induces clustering of integrins, leading to activation of 
intracellular kinases such as Src (2).  
Ligand specificity is an important determinant of integrin activity. Mac-1 belongs 
to a class of integrins that bind ligands mostly through an extra domain on the tip of their 
α subunits. This domain is a metal-binding Rossmann fold domain and is commonly 
referred to as the α I-domain. The canonical ligand binding mechanism of α I-domains 
relies on cooperative coordination of a divalent cation by residues in α I-domain and 
acidic amino acids in the ligand (1). Because the metal ion is important for ligand binding 
and adhesion, the metal binding site in I-domains is commonly known as the metal ion 
dependent adhesion site (MIDAS). This has been observed in structures of α I-ligand 
complexes (3-6). In the binding interface, ligand donates an Asp or Glu to coordinate the 
metal ion in MIDAS, as shown in Figure 4.1. So far, this canonical ligand-binding 
mechanism can explain ligand specificity of most α I-domains. However, there are 
notable exceptions. For instance, α2 I-domain is known to bind a cyclic peptide composed 
entirely of positively charged amino acids (7). More recently, the ligand specificity of 
Mac-1 (αMβ2) was also shown to be outside of the scope specified by the canonical 
mechanism. 
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Figure 4.1 Crystal Structure of αM I-domain with C3d, Complement Component 
C3d Fragment.  
D1247 in C3d (brown) directly coordinates Ni
2+
 ion in the MIDAS of αM I-domain 
(cyan). The interaction interface is enlarged for clear visualization. The ribbon 
structure is produced from pdb: 4m76. 
 
Mac-1 is one of the most promiscuous integrins known. Mac-1 binds ligands as 
distinct as fibrinogen, vitronectin, ICAM-1, iC3b, E-selectin and heparin (8). A 
systematic peptide library screening study showed αM I-domain, which is responsible for 
~ 90 % of Mac-1’s ligand binding activity, preferentially binds to peptides containing 
basic and hydrophobic amino acids, not acidic amino acids. This indicates αM may utilize 
a yet-uncharacterized ligand binding mechanism. Using the consensus Mac-1 binding 
motif identified in the study, several new Mac-1-binding ligands have been discovered, 
including LL-37 (9), dynorphin-A (10), pleiotrophin (PTN) (11) and platelet factor 4 
(PF4/CXCL4) (12), all of which are highly cationic peptides.  
We have been interested in characterizing this novel ligand-binding mechanism of 
αM I-domain. Our hypothesis is based on the fact that cationic proteins such as PTN bind 
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their receptors mainly through electrostatic interactions with acidic amino acid clusters 
on receptors. Analysis of the electrostatic potential on the surface of αM I-domain 
revealed that the most negatively charged region on the domain is in fact around the 
metal-free MIDAS, which possesses several acidic amino acids involved in metal 
coordination. Although binding of divalent cation to MIDAS does neutralize the charges, 
Ca
2+
 and Mg
2+
 affinity of wild type αM I-domain has Kd in the mM range (13), 
significantly lower than other α I-domains. This means a large fraction of αM I-domain 
may remain in the metal-free state under physiological conditions. Based on these 
observations, we believe that MIDAS is the binding site of these cationic ligands and the 
interaction occurs in a metal-independent manner. To confirm this, we have studied 
interactions of αM I-domain with both PTN and PF4 using solution NMR spectroscopy 
and microscale thermophoresis (MST). Our data show wild type αM I-domain binds PTN 
and PF4 in a metal-independent fashion, and both ligands bind close to the MIDAS. In 
addition, MST results indicate high Mg
2+
 concentrations significantly lower αM I-
domain’s affinity for both PTN and PF4, indicating existence of competitive binding 
between these ligands and metal ions. This was confirmed by NMR data that showed that 
presence of PF4 inhibited Mg
2+
 binding. Finally, the binding of these cationic ligands 
does not appear to change the conformation of wild type αM I-domain significantly. These 
data are a first step in understanding the unique mechanism these ligands use to modulate 
Mac-1 activity. 
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4.3 Materials and Methods 
1, Expression and purification of proteins 
The open reading frame (ORF) of the wild type αM I domain (E131-T324) was 
cloned into the pHUE vector as a fusion protein with His-tagged ubiquitin at its 5’ end 
(14). BL21 (DE3) cells transformed with expression vectors were grown in M9 medium 
at 37 °C to an OD600 of ~ 0.8, at which point the culture was induced with 0.5 mM IPTG 
and harvested after overnight incubation at room temperature (23°C). To prepare 
isotopically labeled proteins, 
15
NH4Cl and/or 
13
C glucose was added into M9 media. Post-
induction cell cultures were then harvested, resuspended in lysis buffer (20 mM sodium 
phosphate, 0.5 M Nacl 10 mM imidazole, 5% glycerol, 0.01% NaN3), treated with 
1mg/mL lysozyme for 20 min and sonicated. After centrifugation, supernatant was 
collected and subjected to Ni-affinity chromatography with 5-mL HisTrap column (GE 
Life Sciences). To elute the protein, an imidazole gradient of 35 to 500 mM was applied 
at a flow-rate of 3 mL/min. Eluent fractions containing the fusion proteins (His-tagged-
ubiquitin-integrin αM I domain) were then buffer exchanged into 25 mM Tris and 100 
mM NaCl, pH 8.0 and treated with 1/20 molar equivalent of the His-tagged ubiquitinase 
USP2 catalytic core domain overnight at room temperature to cleave ubiquitin from the 
fusion protein (14). To separate cleaved αM I domain from His-tagged ubiquitin, His-
tagged USP2 and undigested fusion proteins, digestion mixture was passed down a 
second Ni-affinity column. Flow-through was collected and applied to a Superdex 75 size 
exclusion chromatography column (GE Life Sciences) for further purification. Purity of 
the protein in each fraction was verified using SDS-PAGE analysis. 
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PTN (T47C & S106C) expression and purification schemes were performed 
according to previously reported protocols (15). Briefly, pET-15b vector harboring 
human PTN ORF was transformed into Origami B (DE3) cells (Novagen, Madison, WI, 
USA). Cells were grown in M9 medium at 37 °C to an OD600 of 0.5 when 0.25 mM IPTG 
was added before overnight culture at room temperature. Cells were harvested, re-
suspended, treated with lysozyme and sonicated in the same way as mentioned above for 
αM I domain. After centrifugation, supernatant was applied onto 5mL HiTrap SP HP 
column (GE Healthcare Life Sciences) and eluted with 1 M NaCl gradient.  
Cloning and culture of PF4 (S26C) is the same as PTN. Purification was 
accomplished using a 5mL HisTrap Heparin HP affinity column (GE Life Sciences) and 
eluted with a 0.1 to 3 M NaCl gradient. PF4 fractions were buffer exchanged and 
concentrated in 20 mM acetate, 150 mM NaCl buffer (pH 5.0). 
2, NMR data acquisition and backbone assignment 
All data were collected on Bruker AVANCE 600 MHz and 850 MHz 
spectrometers equipped with cryo-probes. All NMR samples contain 0.15-1 mM αM I 
domain in 20 mM HEPES and 100 mM NaCl (pH 7.0). For backbone assignment, 
HNCACB, HNCOCACAB, HNCO and HNCACO spectra were collected on 
2
H/
13
C/
15
N 
integrin samples. In addition, 
13
C/
15
N integrin was used to collect HNCA, HNCOCA, 
HNCO and HNCACO spectra. To assist backbone assignment, CCCONH and 
15
N-edited 
NOESY spectra were also acquired. All NMR data were processed with NMRPipe (16) 
and analyzed with NMRView (17). 
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To probe the PF4-induced chemical shift change, 
1
H-
15
N HSQC spectra were 
acquired for a sample containing 150 uM 
15N αM I domain only and another sample 
containing 500 uM PF4 and 150 uM 
15N αM I domain at 0 and 10 mM Mg
2+
. Chemical 
shift changes on 
1
H and 
15
N dimensions of the two spectra were quantified using one 
single chemical shift value δ (δ = [ΔδH
2
 + (0.2 ΔδN)
2
]
1/2
) (18). 
To examine the competition of Mg
2+
 and PF4, 
1
H-
15
N HSQC spectra of 150 uM 
15
N αM I domain were collected at 0 and 10 mM Mg
2+
. The same spectra were acquired 
with 150 uM 
15
N αM I domain and 500 uM of PF4 at 0, 10 and 50 mM Mg
2+
. 
3, Paramagnetic relaxation enhancement (PRE) 
To paramagnetically label PTN, purified PTN was immediately buffer exchanged 
to PBS buffer and mixed with 10 molar equivalents of MTSL (1-Oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl) methanethiosulfonate (Santa Cruz Biotechnology) for 
overnight incubation. Then the mixture is buffer exchanged to 10 mM MES, 150 mM 
NaCl buffer (pH 6.0) to remove unreacted MTSL. MTSL-labeled PF4 was created in a 
similar fashion. Specifically, MTSL was added directly to the combined PF4 fractions for 
overnight labeling before being removed by buffer exchanging the mixture into 20 mM 
acetate, 150 mM NaCl buffer (pH 5.0). The MTSL labeling efficiency was verified by 
comparing 1D 
1
H NMR spectra before and after addition of ascorbic acid. 
To measure PTN-induced PRE perturbations on αM I domain, two samples (~ 300 
uL, pH 7.0) samples containing 150 uM 
15N αM I domain and 900 uM MTSL-tagged 
S106C or T47C PTN were prepared. 2.8 uL 0.5M ascorbic acid was added to one sample 
to reduce the radical to its diamagnetic form (19). pH of both samples was checked to 
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ensure absence of artifacts due to pH difference. PRE effects from MTSL-tagged PTNs 
were analyzed by comparing 
1
H-
15
N HSQC spectrum of diamagnetic sample with that of 
paramagnetic sample. The experiments were repeated with no Mg
2+
 or with 10 mM Mg
2+
. 
To investigate the effect of Mg
2+
on ligand affinity, 150 uM of 
15N αM I domain and 150 
uM MTSL-tagged S106C PTN were mixed without Mg
2+
 or with 50 mM Mg
2+
. PF4 
experiments were performed similarly with the exception that only 500 uM MTSL-
tagged PF4 S26C added to 150 uM 
15N αM I domain at pH 6.6. pH of all samples were 
checked to rule out artifacts from pH variations. 
4, Microscale thermophoresis (MST) 
The binding affinity of PTN or PF4 to wild type αM I-domain was determined by 
MST in the presence and absence of Mg
2+
. The MST experiment was performed using 
Monolith NT.115 (Nanotemper). The protein was randomly labeled with DyLight 488 
NHS Ester dyes (Thermo Scientific) through amine groups on the protein following the 
instructions from manufacturer. For optimal labeling efficiency, the protein was buffer 
exchanged to 0.05M sodium borate buffer at pH 8.5 and concentrated to 5mg/mL. The 
DyLight 488 NHS-Ester was dissolved in DMF. Protein was then mixed with 5 molar 
equivalents of DyLight 488 NHS-Ester and incubated at room temperature for 1 hour. 
The unreacted dyes were removed from labeled protein by buffer exchanging the protein 
to 20mM HEPES and 100mM NaCl pH 7.0 buffer. The degree of labeling was calculated 
based on the protocol from manufacturer and there are 2.7 moles dye per mole protein. 
For PTN titrations, the samples were prepared in the buffer of 20mM HEPES, 100mM 
NaCl, 0.05% Tween 20, pH 7.0 with varied concentration of Mg
2+
(no Mg
2+
, 1mM Mg
2+
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or 50mM Mg
2+
) For PF4 titration, the samples were prepared in same buffer with pH 6.0 
to prevent PF4 precipitations. αM I-domain mutants were prepared in the same way as the 
WT αM I-domain. Each MST sample contains ~ 10 µL of 50 nM DyLight 488-labeled αM 
I-domain in the presence of different concentrations of PTN or PF4 and placed in 
Standard treated capillaries (Nanotemper). Data was collected from three measurements 
and calculated for the standard deviation as error. The binding constant Kd was 
calculated by fitting the plot of normalized changes in fluorescence due to 
thermophoresis (ΔFnorm) vs concentrations of the ligand using the equation 𝑓(𝐿) =
𝑈𝑛𝑏𝑜𝑢𝑛𝑑 +
(𝐵𝑜𝑢𝑛𝑑−𝑈𝑛𝑏𝑜𝑢𝑛𝑑)×(𝐿+𝑃+𝐾𝑑−√(𝑙+𝑃+𝐾𝑑)2−4×𝐿×𝑃)
2×𝑃
 where Bound is the MST 
response value of αM I-domain fully saturated with the ligand, Unbound is the response 
value of αM I-domain in the absence of the ligand, L is the ligand concentration, P is the 
concentration of αM I-domain. 
4.4 Results 
1, αM I-domain’s interaction with PTN & PF4 is metal-independent  
Divalent cations such as Ca
2+
 or Mg
2+
 are usually essential to ligand binding 
activities of integrins. However, absence of acidic amino acids in many αM ligands begs 
the question of whether αM I-domain’s interactions with these ligands are metal mediated. 
To test this hypothesis, we measured the affinity of αM I-domain for PTN and PF4 using 
microscale thermophoresis (MST). Both PTN and PF4 induced significant changes in 
thermophoresis of fluorescently labeled αM I-domain (Figure 4.2). Both proteins also 
caused αM I-domain to migrate towards the heat source, indicating the complex they form 
with αM I-domain have similar physical properties. However, the affinity of αM I-domain 
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for PTN is slightly higher than that for PF4 (Kd of ~1 and ~6 µM, respectively) More 
importantly, both proteins bind αM I-domain even in the absence of Mg
2+
 and addition of 
physiological concentration of Mg
2+
 (1 mM) did not change the affinity (Figure 4.2). This 
implies metal is not essential to interactions of these ligands with αM I-domain. 
 
Figure 4.2 MST Analysis of αM I-domain’s Interactions with PTN and PF4.  
(A), Thermophoresis of Dylight 488 labeled αM I-domain was measured at different 
concentrations of PTN. Left panel is the fluorescent time traces during 
thermophoresis. Right panel is the binding curves obtained from fitting the 
thermophoresis signals at different Mg
2+
 concentrations. (B), Thermophoresis of 
Dylight 488 labeled αM I-domain was measured at different concentrations of PF4. 
Left panel is the fluorescent time traces during thermophoresis. Right panel is the 
binding curves obtained from fitting the thermophoresis signals at different Mg
2+
 
concentrations. 
Because Mg
2+
 affinity of αM I-domain is relatively low ( Kd ~ 1 mM) (13), 
MIDAS in αM I-domain is likely not fully saturated at physiological Mg
2+
 concentrations. 
In order to investigate the effect of metal-saturation on the binding of PTN and PF4 αM I-
domain, we also measured αM I-domain’s affinity for these ligands in the presence of 50 
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mM Mg
2+
. Surprisingly, data showed higher Mg
2+
 concentration significantly lowered the 
affinity of αM I-domain for these ligands. In particular, αM I-domain’s Kd for PTN 
increased from 1 µM to 50 µM while its Kd for PF4 increased from 6 µM to 35 µM 
(Figure 4.2). To ensure the effect is not entirely due to change in ionic strength, we also 
carried out control experiments in which NaCl concentration in the buffer is increased by 
100 mM. The results showed ionic strength alone only accounts for ~ 50 % of the 
decrease in affinity in the case of PTN (Figure 4S1). Similar analysis on PF4’s interaction 
with αM I-domain showed the increase in ionic strength can account for all the decrease in 
αM I-domain’s affinity for PF4. These results imply the interactions between the cationic 
ligands and αM I-domain relies mainly on electrostatic interactions and divalent metal 
ions such as Mg
2+
 have high specificity as competitive inhibitors of PTN, contrary to 
other ligands that bind αM I-domain through the metal.  
2, NMR analysis of PTN-αM I-domain interactions 
To determine the binding site of the cationic ligands on αM I-domain, we initially 
attempted chemical shift perturbation mapping, which uses environmental sensitivity of 
amide hydrogen and nitrogen chemical shifts to locate residues at the ligand binding 
interface. However, no significant changes in the 
15
N-HSQC spectrum of αM I-domain 
were induced even with high concentrations of PTN ( ~ six molar equivalents). This is 
typical of interactions that are transient and dynamic in nature. To increase the sensitivity 
at which ligand binding can be detected, we created paramagnetically tagged PTN 
variants by mutating S106 or T47 to cysteine, which can be conjugated to the cysteine 
reactive paramagnetic compound MTSL (S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-
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pyrrol-3-yl)methyl methanesulfonothioate). Similar to NOE, paramagnetic radicals have 
strong dipolar interactions with nuclei in a distance dependent manner. However, because 
electron has a larger gyromagnetic ratio than protons, paramagnetic effects have a longer 
range than NOE. The presence of such a paramagnetic center in the vicinity of other 
atoms increases the transverse relaxation rates (R2) of these atoms, resulting in 
considerable signal intensity loss. This effect is commonly referred to as paramagnetic 
relaxation enhancement, or PRE. The long effective range of PRE makes it an ideal 
technique for probing transient and dynamic interactions between biomolecules. 
3, NMR analysis of PTN-αM I-domain interactions 
To determine the binding site of the cationic ligands on αM I-domain, we initially 
attempted chemical shift perturbation mapping, which uses environmental sensitivity of 
amide hydrogen and nitrogen chemical shifts to locate residues at the ligand binding 
interface. However, no significant changes in the 
15
N-HSQC spectrum of αM I-domain 
were induced even with high concentrations of PTN ( ~ six molar equivalents). This is 
typical of interactions that are transient and dynamic in nature. To increase the sensitivity 
at which ligand binding can be detected, we created paramagnetically tagged PTN 
variants by mutating S106 or T47 to cysteine, which can be conjugated to the cysteine 
reactive paramagnetic compound MTSL (S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-
pyrrol-3-yl)methyl methanesulfonothioate). Similar to NOE, paramagnetic radicals have 
strong dipolar interactions with nuclei in a distance dependent manner. However, because 
electron has a larger gyromagnetic ratio than protons, paramagnetic effects have a longer 
range than NOE. The presence of such a paramagnetic center in the vicinity of other 
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atoms increases the transverse relaxation rates (R2) of these atoms, resulting in 
considerable signal intensity loss. This effect is commonly referred to as paramagnetic 
relaxation enhancement, or PRE. The long effective range of PRE makes it an ideal 
technique for probing transient and dynamic interactions between biomolecules. 
To carry out these PRE experiments, two samples of 
15
N-labeled αM I-domain 
mixed with six molar equivalents of MTSL-PTN were prepared. MTSL in one of the 
samples was kept in the paramagnetic state while MTSL in the other was reduced to the 
diamagnetic nitroxyl form using ascorbic acid. 
15
N HSQC spectrum was acquired for 
each sample and peak intensity of each signal was then tabulated. Figure 4.3A shows 
sections from HSQC spectra of αM I-domain in the presence of paramagnetic and 
diamagnetic S106C-tagged MTSL-PTN. S106 is located in the C-terminal domain (CTD) 
of PTN and PRE effects from this mutant are indicative of closeness of the CTD to αM I-
domain. This version of MTSL-PTN produced significant PRE effects on residues close 
to MIDAS. Specifically, G207 in the second MIDAS segment has the most significant 
PRE with an intensity decrease of > 90 % in the presence of paramagnetic MTSL-PTN. 
Residues G247 also showed measurable decreases in its intensity, but to a lesser degree 
(Figure 4.3B). Since both residues are close to MIDAS (Figure 4.3C), these results 
indicate MIDAS is the primary binding site for PTN. A control experiment has also been 
carried out using free MTSL to ensure the paramagnetic effect is not because of non-
specific interactions between MTSL and αM I-domain. As expected, free MTSL does not 
produce the strong paramagnetic perturbation observed with MTSL-labeled PTN (Figure 
4S2). 
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To carry out these PRE experiments, two samples of 
15
N-labeled αM I-domain 
mixed with six molar equivalents of MTSL-PTN were prepared. MTSL in one of the 
samples was kept in the paramagnetic state while MTSL in the other was reduced to the 
diamagnetic nitroxyl form using ascorbic acid. 
15
N HSQC spectrum was acquired for 
each sample and peak intensity of each signal was then tabulated. Figure 4.3A shows 
 
Figure 4.3 Effects of Paramagnetic PTN on HSQC of αM I-domain. 
(A), Residue specific intensity decreases induced by MTSL-labeled PTN. Secondary 
structures of αM I-domain as well as segments forming the MIDAS (in green) are 
indicated on top of bar charts. Uncertainty in intensity ratio is calculated using the 
formula  
𝑰𝒑𝒂𝒓𝒂
𝑰𝒅𝒊𝒂
√(
∆𝑰𝒅𝒊𝒂
𝑰𝒅𝒊𝒂
)𝟐 + (
∆𝑰𝒑𝒂𝒓𝒂
𝑰𝒑𝒂𝒓𝒂
)𝟐. (B), Sections of αM I-domain 
15
N HSQC spectra in 
the presence of either paramagnetic (blue) or diamagnetic (black) MTSL-labeled 
PTN. (C) Ribbon representation of αM I-domain showing the positions of residues 
with the strongest PRE. 
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sections from HSQC spectra of αM I-domain in the presence of paramagnetic and 
diamagnetic S106C-tagged MTSL-PTN. S106 is located in the C-terminal domain (CTD) 
of PTN and PRE effects from this mutant are indicative of closeness of the CTD to αM I-
domain. This version of MTSL-PTN produced significant PRE effects on residues close 
to MIDAS. Specifically, G207 in the second MIDAS segment has the most significant 
PRE with an intensity decrease of > 90 % in the presence of paramagnetic MTSL-PTN. 
Residues G247 also showed measurable decreases in its intensity, but to a lesser degree. 
Since both residues are close to MIDAS, these results indicate MIDAS is the primary 
binding site for PTN. A control experiment has also been carried out using free MTSL to 
ensure the paramagnetic effect is not because of non-specific interactions between MTSL 
and αM I-domain. As expected, free MTSL does not produce the strong paramagnetic 
perturbation observed with MTSL-labeled PTN (Figure 4S2). 
PTN is composed of two structured domains with similar folds (15). Previous 
study showed the N-terminal domain (NTD) and CTD can bind αM I-domain 
independently, but CTD’s affinity for αM I-domain is higher than that of NTD (11). To 
determine if NTD of PTN binds to the same site on αM I-domain as CTD, we also 
prepared the T47C PTN mutant, which allows us to place the MTSL tag on NTD. Similar 
PRE experiments showed the T47C mutant perturbed the same set of αM I-domain 
residues as the S106C mutant (Figure 4.3). Interestingly, the magnitude of PRE from 
NTD-tagged PTN is similar to that of the CTD-tagged mutant even though NTD is 
known to have a lower affinity for αM I-domain than CTD. This result is likely due to 
several factors. Specifically, the location of the NTD MTSL tag may be closer to αM I-
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domain than the CTD MTSL tag, allowing it to produce similar levels of perturbation 
despite its lower affinity. It is also possible that NTD and CTD in wild type PTN is not as 
independent as once assumed, thereby allowing NTD in wild type PTN to have as high an 
affinity for αM I-domain as CTD in wild type PTN. It is also possible that, because PTN’s 
concentration is high, NTD can saturate αM I-domain even with its lower affinity. 
 
Figure 4.4 Effects of 50 mM Mg
2+
 on PTN’s Interaction with αM I-domain.  
(A), Sections of αM I-domain HSQC spectra in the presence of one molar equivalents 
of either paramagnetic (blue) or diamagnetic (black) PTN whose CTD contains the 
MTSL tag. 50 mM Mg
2+
 induced significant decreases in the observed PRE G207. 
(B), Residue specific intensity decreases induced by CTD MTSL-labeled PTN in the 
absence and presence of 50 mM Mg
2+. Secondary structures of αM I-domain as well 
as residues and regions forming the MIDAS are indicated on top of bar charts. 
G207 is shown in red. Uncertainty in intensity ratio is calculated using the formula 
𝑰𝒑𝒂𝒓𝒂
𝑰𝒅𝒊𝒂
√(
∆𝑰𝒅𝒊𝒂
𝑰𝒅𝒊𝒂
)𝟐 + (
∆𝑰𝒑𝒂𝒓𝒂
𝑰𝒑𝒂𝒓𝒂
)𝟐. 
 
MST results showed high Mg
2+
 concentrations can inhibit the binding of PTN to 
αM I-domain. To confirm these data, we also investigated the effect of Mg
2+
 on 
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interactions of αM I-domain with PTN using NMR. Interestingly, even though MST 
showed 50 mM Mg
2+
 weakens PTN-αM I-domain interactions considerably, this effect 
was not initially observed in the PRE experiments. We attribute this to the high 
concentration of PTN used in NMR experiments, which leaves most of αM I-domain in 
the PTN-bound form even with a binding Kd of 50 µM. On the other hand, the fraction of 
PTN-bound αM I-domain decreases to only 54 % if the PTN concentration is reduced to 
just one molar equivalent. This difference is sufficiently large to be detected by NMR. 
We therefore compared signal intensities of αM I-domain in the presence of only one 
molar equivalent of either paramagnetic or diamagnetic MTSL-PTN. The data showed 
presence of 50 mM Mg
2+
 reduced perturbation to G207 significantly as PRE-related 
intensity decrease reduced from ~50 % to 25 % when Mg
2+
 concentration is high (Figure 
4.4). This provides additional support for competitive binding between cationic peptides 
and Mg
2+
 ions. 
 
Figure 4.5 PF4-induced Chemical Shift Changes in 
15
N HSQC Spectrum of αM I-
domain. (A), 
15
N-HSQC spectra of αM I-domain in the presence (red) and 
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4, NMR analysis of PF4-αM I-domain interactions 
PF4 is another highly positively charged protein that has been identified as a 
potent ligand of Mac-1 capable of inducing Mac-1-dependent activation of macrophage 
and neutrophils (12). We examined interactions of PF4 with αM I-domain using the same 
suite of NMR experiments used to study PTM-αM I-domain interactions. Interestingly, 
unlike PTN, PF4 did induce measurable changes in the 
15N HSQC spectrum of αM I-
domain (Figure 4.5). Most residues perturbed by PF4 are also located around MIDAS, 
indicating the PF4 binding site is also close to MIDAS. In addition, the set of residues 
perturbed by PF4 overlaps significantly with the set of residues perturbed by Mg
2+
 
binding (Figure 4S3). Chemical shift mapping also revealed that MIDAS residues, 
especially three loops containing direct coordinating residues, are the Mg
2+
 binding sites 
as they have the most significant chemical shift change upon metal bindings. The 
perturbation pattern is similar to α1 I domain (23). This is also consistent with MIDAS 
being the binding site for PF4.  
absence (blue) of 3.3 molar equivalents of PF4. No Mg
2+
 is present in the buffer. 
(B), Residue specific chemical shift changes in αM I-domain. Chemical shift 
changes are calculated as √∆H𝟐 + (𝟎. 𝟐𝟓 ∗ ∆N)𝟐. Secondary structures of αM I-
domain as well as residues and regions forming the MIDAS are indicated on top 
of bar charts. (C), Ribbon representation of  αM I-domain showing positions of 
residues with significant PF4-induced chemical shift changes. 
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Figure 4.6 Effects of Paramagnetic PF4 on HSQC of αM I-domain.  
(A), Residue specific intensity decreases induced by CTD MTSL-labeled PTN. Note 
that 10 mM Mg
2+
 does not have a significant effect on the binding of these ligands. 
Secondary structures of αM I-domain as well as residues and regions forming the 
MIDAS are indicated on top of bar charts. Residues having intensity decrease 
greater than 15 % are shown in red. Uncertainty in intensity ratio is calculated 
using the formula 
𝑰𝒑𝒂𝒓𝒂
𝑰𝒅𝒊𝒂
√(
∆𝑰𝒅𝒊𝒂
𝑰𝒅𝒊𝒂
)𝟐 + (
∆𝑰𝒑𝒂𝒓𝒂
𝑰𝒑𝒂𝒓𝒂
)𝟐 . (B), Sections of αM I-domain HSQC 
spectra in the presence of 3.3 molar equivalents of either paramagnetic (blue) or 
diamagnetic (black) PF4. (C), Ribbon representation of αM I-domain showing the 
positions of residues with the strongest PRE. 
 
To confirm results from chemical shift mapping, we probed αM I-domain with a 
PF4 variant containing the S17C mutation, which can anchor the paramagnetic MTSL tag 
close to the N-terminus of the protein. Similar to PTN, addition of MTSL-labeled PF4 
strongly perturbed residue G207 close to the MIDAS (Figure 4.6). Residue G143 was 
also perturbed significantly by MTSL-labeled PF4. Once again, both residues are close to 
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MIDAS and the perturbation pattern agrees with the hypothesis that MIDAS is the 
binding site for cationic ligands. 
To understand how Mg
2+
 ions affect PF4-αM I-domain interaction, we measured 
the effect of different concentrations of Mg
2+
 on interactions between αM I-domain and 
PF4. Similar to PTN, 10 mM Mg
2+
 does not change the PRE magnitude elicited by 
MTSL-labeled PF4. However, 10 mM Mg
2+
, which was sufficient to completely 
eliminate signals from metal free αM I-domain in the presence of six molar equivalents of 
PTN, produced two sets of signals in αM I-domain’s 
15
N HSQC spectrum even when less 
than four equivalents of PF4 are present. Comparison with the spectrum of metal free αM 
I-domain in the presence of PF4 showed signal doubling is the result of incomplete Mg
2+
 
saturation since one set of signals corresponds to metal free αM I-domain while the other 
set agrees with the Mg
2+
-bound form of αM I-domain (Figure 4.7). The reason for signal 
doubling was confirmed when two sets of signals coalesced into a single set of signals 
when Mg
2+
 ion concentration was increased to 50 mM. These results indicate PF4 
interferes with Mg
2+
 binding and are consistent with MIDAS being the binding site for 
both PF4 and the Mg
2+
 ion. 
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Figure 4.7 PF4 Inhibits Mg
2+
 Binding of αM I-domain.  
Selective signals in the HSQC of αM I-domain at 0, 10 and 50 mM Mg
2+
. These 
residues display double resonances in the presence of 10 mM Mg
2+
. The chemical 
shifts of the two resonances are consistent with existence of a significant population 
of Mg
2+
-free αM I-domain. Signals from this population were not seen at 50 mM 
Mg
2+
. 
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Figure 4.8 Effects of Acidic Amino Acid Mutations on the Binding Affinity of PTN 
to αM I-domain.  
MST-derived binding curves of PTN to E178,179S αM I-domain as well as 
E253S/D254S αM I-domain. Both sets of mutations measurably reduce affinity of αM 
I-domain for PTN. 
 
5, Conformation of αM I-domain is not changed by ligand binding 
Activation of Mac-1 leads to conformation changes in αM I-domain that includes a 
shift of the C-terminal helix away from MIDAS (24). This conformation change is 
believed to be crucial to increasing the ligand affinity of αM I-domain in metal-mediated 
interactions. To understand whether the binding of cationic ligands can produce similar 
changes in the conformation of αM I-domain, we mutated residue G321 at the C-terminus 
of αM I-domain to cysteine. This allows attachment of MTSL to the C-terminus of αM I-
domain. Our hypothesis is that shift of the C-terminal helix away from the protein should 
lead to a decrease in its paramagnetic effect on nearby residues, which can be easily 
detected by NMR. To test this, we measured intramolecular PRE of the MTSL tag on αM 
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I-domain in the presence and absence of four molar equivalents of PF4. Figure 4.9 shows 
the results from these experiments. It is clear that presence of PF4 did not have a 
significant effect on intramolecular PRE from the MTSL tag, indicating PF4 binding does 
not change the conformation of αM I-domain. 
4.5 Discussion 
MST experiments carried out in this study demonstrated for the first time that, not 
only are cationic ligands’ interactions with αM I-domain independent of divalent cations, 
high concentrations of divalent cations in fact inhibit binding of these ligands to αM I-
domain. Solution NMR studies of the same systems have convincingly identified MIDAS 
as the binding site of these ligands. This is not a surprise because many of the cationic 
ligands are known to seek out negatively charged regions on receptors and MIDAS in αM 
I-domain has several negatively charged amino acid clusters in its vicinity. The 
dominance of electrostatic interactions between αM I-domain and the ligands explains 
why high divalent cation concentrations inhibit the binding. It is worth noting that, 
although there is one report of α2 I-domain MIDAS being the binding site of a cationic 
peptide (7), this is the first study to demonstrate ligands can bind α I-domains using a 
completely metal independent mechanism. This mechanism differs significantly from the 
canonical ligand binding mechanism of integrin I-domains, which stipulates that ligands 
must bind I-domain through divalent cation mediated interactions that involve acidic 
amino acids from both the ligand and α I-domain MIDAS, thereby allowing the metal to 
act as a glue between the ligand and α I-domain. In contrast to the canonical mechanism, 
interactions between cationic ligands and αM I-domain are unaffected by the absence of 
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divalent cations and physiological concentrations of Mg
2+
 does not increase ligand 
binding at all. At high Mg
2+
 concentrations, the affinity of αM I-domain for cationic 
ligands is weakened considerably as Mg
2+
 is able to compete for the same binding site as 
the cationic ligands. Additional experiments carried out using αM I-domain mutants 
missing some of the acidic amino acid clusters around MIDAS show these amino acids 
do indeed participate in binding. Interestingly, two of the amino acids investigated, E253 
and D254, were also identified as important in defining αM I-domain’s ligand specificity 
in a previous study (8). It should also be noted that basic amino acids in ligands do play 
important roles in αL I-domain’s interaction with ICAM-1 as well as in αM I-domain’s 
interaction with iC3b, even though both interactions follow the canonical mechanism as 
well (6,25). However, it appears that αM I-domain has also evolved to have a sufficient 
amount of electronegativity around its MIDAS to bind ligands without the help of 
divalent cations. 
 These cationic ligands are by no means equivalent to each other. Although both 
PTN and PF4 bind to the same site on αM I-domain. There are significant differences in 
how they interact with αM I-domain. In particular, PF4 was able to prevent Mg
2+
 binding 
to αM I-domain to a significant degree. Because lowered Mg
2+
 affinity would make Mg
2+
 
less effective in neutralizing MIDAS, this may explain why Mg
2+
-induced decreases in 
PF4 affinity has the same magnitude as NaCl. PF4 was also able to elicit considerable 
chemical shift changes in the 
15N HSQC spectrum of αM I-domain, which PTN was not 
able to do. This indicates PF4’s interaction with αM I-domain may be more specific and 
stable than that of PTN. 
91 
 
All experiments in this study were conducted using wild type αM I-domain, which 
adopts the inactive conformation. The fact that these cationic ligands are able to bind the 
domain even when it is in the inactive conformation implies their affinity for the active 
conformation of the αM I-domain should be even higher. Our previous biolayer 
interferometry studies of both PTN and PF4’s interactions with active and inactive αM I-
domain showed this is indeed the case (11,12). However, this does not mean only 
activated αM I-domain can bind the ligands. In particular, both PTN and PF4 are avid 
binders of glycosaminoglycans and are believed to be displayed in oligomeric or 
aggregated forms in the extracellular space as a result of these interactions (26,27). These 
large multivalent aggregates would have much higher affinity for inactive αM I-domain as 
a result of avidity of interaction. This potentially makes inactive Mac-1 a viable receptor 
for the ligands. The fact that these ligands are immobilized on cell surface or in the 
extracellular matrix is also consistent with current model of integrin activation (28). It is 
also interesting to note that there is currently no evidence that binding of these ligands to 
αM I-domain can shift the conformational equilibrium of αM I-domain towards the active 
conformation despite numerous cell-based assays showing these ligands are capable of 
activating Mac-1 (11,12). One possible mechanism by which these ligands can activate 
Mac-1 is through ligand-induced Mac-1 clustering. Oligomeric forms of these ligands can 
bind multiple integrin receptors, potentially inducing their clustering. Since it is well 
known that clustering of integrins is essential to activation of integrin associated Src 
family of phosphotyrosine kinases and subsequently to activation of other pathways 
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(2,29), binding of Mac-1 to the oligomeric forms of these cationic ligands should activate 
intracellular signaling even if the receptors may not be in the active form. 
I-domain should be even higher. Our previous biolayer interferometry studies of 
both PTN and PF4’s interactions with active and inactive αM I-domain showed this is 
indeed the case (11,12). However, this does not mean only activated αM I-domain can 
bind the ligands. In particular, both PTN and PF4 are avid binders of glycosaminoglycans 
and are believed to be displayed in oligomeric or aggregated forms in the extracellular 
space as a result of these interactions (26,27). These large multivalent aggregates would 
have much higher affinity for inactive αM I-domain as a result of avidity of interaction. 
This potentially makes inactive Mac-1 a viable receptor for the ligands. The fact that 
these ligands are immobilized on cell surface or in the extracellular matrix is also 
consistent with current model of integrin activation (28). It is also interesting to note that 
there is currently no evidence that binding of these ligands to αM I-domain can shift the 
conformational equilibrium of αM I-domain towards the active conformation despite 
numerous cell-based assays showing these ligands are capable of activating Mac-1 
(11,12). One possible mechanism by which these ligands can activate Mac-1 is through 
ligand-induced Mac-1 clustering. Oligomeric forms of these ligands can bind multiple 
integrin receptors, potentially inducing their clustering. Since it is well known that 
clustering of integrins is essential to activation of integrin associated Src family of 
phosphotyrosine kinases and subsequently to activation of other pathways (2,29), binding 
of Mac-1 to the oligomeric forms of these cationic ligands should activate intracellular 
signaling even if the receptors may not be in the active form. 
93 
 
CHAPTER 5 
CONFORMATIONAL DYNAMICS OF INTEGRIN αM I-DOMAIN  
5.1 Abstract 
 Mac-1 has a broad spectrum of ligands and is one of the most promiscuous 
members of the integrin family. α I-domain, as the primary ligand binding site, has 
interesting conformational dynamics not seen in other α I-domains.  Using NMR 
relaxation dispersion experiments, µs-ms timescale motions were discovered in αM I-
domain. Specifically, the slow motions are intrinsic in MIDAS, the ligand binding site of 
the α I-domain. Mg2+ induced motions at similar time scales are also found in the crucial 
α7 helix. These motions hint at a possible role played by dynamics in ligand binding as 
well as integrin activation. 
5.2 Introduction 
 Proteins are macromolecules with intrinsic and functional motions. The 
motions include both backbone and side chain bond rotations that can modulate important 
events such as allosteric regulation, ligand interactions etc. The dynamics processes fall 
into different time regimes. They can range from picosecond to nanosecond (ps-ns) and 
microsecond to millisecond (µs-ms). Nuclear magnetic resonance (NMR) has emerged as 
a powerful tool as it is capable of probing a wide range of motional timescales with 
different experiments (1,2). Figure 5.1 displays an overview of protein motion timescales 
and specific NMR experiments for them. The most frequently explored motions are fast 
(ps-ns) and slow (µs-ms). 
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 Briefly, fast motions (ps-ns) are probed with R1, R2 and heteronuclear NOE 
(nuclear Overhauser effect) experiments. R1 refers to longitudinal relaxation rate of 
magnetization along the static magnetic field from excited state to equilibrium while R2 
represents transverse relaxation rate of transverse magnetization coherence dephasing (3). 
Both R1 and R2 relaxations stem from variations in local magnetic field due to chemical 
shift anisotropy (CSA) and dipolar coupling, and are dependent on both global and 
internal motions of proteins (4,5). The NOE is the steady state NOE enhancement due to 
dipolar cross relaxation, which is also dependent on protein motion (6). In practices, R1, 
R2 and heteronuclear NOE are measured in combination  and the data can be subjected to 
the Lipari-Szabo model free analysis (7,8). The order parameter S
2
 , a parameter for local 
motion amplitude, and correlation time τc for each residue can be obtained through such 
an analysis (9). This approach was explored in Chapter 2 to examine the effect of 
glycosaminoglycan bindings on the conformational dynamics of DBPB. 
 
Figure 5.1 Protein Motions at Various Timescales and NMR Techniques for Each 
Timescale 
Reprinted with permission from Ortega, G., Pons, M., and Millet, O. (2013) Protein 
functional dynamics in multiple timescales as studied by NMR spectroscopy. Advances in 
protein chemistry and structural biology 92, 219-251. Copyright (2013) Elsevier. See 
Appendix J. 
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Figure 5.2 Signal Intensity Changes under Various νCPMG in CPMG Relaxation 
Dispersion Experiments.  
(a-c), signal traces simulated for group of nuclei exchanging between two states with 
different chemical shifts during 20 ms of relaxation delay (TCPMG). Vertical bars are 
180° refocusing pulses. (d), Signal intensity increase with higher νCPMG in simulation. 
(e), R2 is plotted against νCPMG=1/(2τcp).  τcp is the delay between consecutive 180° 
refocusing pulses. 
Reprinted with permission from Mittermaier, A. K., and Kay, L. E. (2009) Observing 
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biological dynamics at atomic resolution using NMR. Trends in biochemical sciences 34, 
601-611. Copyright (2009) Elsevier.  See Appendix K. 
  
 Other than CSA and dipolar coupling, R2 rate can also be influenced by slow 
time scale conformational and chemical exchanges. In particular, changes in 
conformation and chemical state may cause spins to constantly switch between different 
magnetic environments and thus have different chemical shifts. Exchanges might also 
arise from ligand bindings. If the exchange happens at the appropriate NMR time scale 
(µs-ms), it leads to faster loss of magnetic moment coherence, thereby increasing the R2 
of the atom. This additional term to the intrinsic transverse relaxation rate R2
0
, Rex, leads 
to a larger transverse relaxation rate R2 and therefore line broadening (10). The 
calculation of R2 in NMR spectra with chemical exchange processes is described by the 
Bloch-McConnell Equations (11). Abergel et al. proposed approximate solutions to the 
Bloch-McConnell Equations for a two-state chemical exchange model as follows (12): 
𝑅2 = 𝑅2
0̅̅̅̅ + 𝑝𝐴𝑝𝐵∆𝜔
2𝑘𝑒𝑥 × [
𝑘𝑒𝑥
2 +∆𝜔2
[𝑘𝑒𝑥
2 +∆𝜔2]
2
−𝑝𝐴𝑝𝐵(5𝑘𝑒𝑥
2 +∆𝜔2)∆𝜔2
] 
𝛺 = ?̅? − 𝑝𝐴𝑝𝐵(𝑝𝐴−𝑝𝐵)∆𝜔
3 × [
𝑘𝑒𝑥
2 +∆𝜔2
[𝑘𝑒𝑥
2 +∆𝜔2]
2
−𝑝𝐴𝑝𝐵(7𝑘𝑒𝑥
2 +3∆𝜔2)∆𝜔2
] 
in which, 𝑅2
0̅̅̅̅ = 𝑝𝐴𝑅2𝐴 + 𝑝𝐵𝑅2𝐵 , ?̅? = 𝑝𝐴𝛺𝐴 + 𝑝𝐵𝛺𝐵 ; R2 and Ω are the transverse 
relaxation rate and resonance frequency of the dominant signal respectively; ρA and ρB 
are populations of the major (A) and minor (B) states; ∆ω is the difference between ΩA 
and ΩB, where ΩA and ΩB are resonance frequencies in states A and B without chemical 
exchange; R2A and R2B are the intrinsic transverse relaxation rates of A and B states. 
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Unlike the intrinsic R2
0
, effect of Rex can be greatly mitigated if spins can be refocused in 
time through application of 180 ͦ refocusing pulses. This provides a method by which 
motions at this timescale (µs-ms) can be quantified using the well-established Carr-
Purcell-Meiboom-Gill (CPMG) scheme in experiments commonly referred to as 
relaxation dispersion (RD) experiments (13,14). Figure 5.2 illustrates how resonance 
signal intensity changes in response to varying νCPMG [reprinted from (15)]. An advantage 
of CPMG technique is that information on the functionally critical minor state (low 
populated) can be obtained by observing only the major state. This is extremely 
convenient since the minor state is often not observable in NMR spectra (2). The 
constant-time CPMG experiment is exploited to investigate the µs-ms motions of integrin 
αM I-domain in the current study. 
 Conformational changes in integrin α I-domains are central to ligand bindings 
and activation (16,17). Specifically, during activation, α I-domain undergoes 
conformational changes, of which the most distinctive is the downward shift of the C-
terminal 7 helix (16). The changes in the conformation of the α I-domain is 
accompanied by a drastic increase in the ligand affinity of α I-domains, making this a 
crucial event in the activation of integrins. Like other integrin α I-domains, αM I-domains 
can reside either in the low ligand affinity state or the high ligand affinity state, as 
evidenced by crystal structures (18,19). This is also supported by studies using 
conformation-specific antibodies (20,21). Additional studies on the αM I-domain has 
shown that residue I316 in the α7 helix has extensive interactions with a hydrophobic 
patch on the protein core, thereby stabilizing the position of the helix. To activate the α I-
98 
 
domain, these hydrophobic interactions are disrupted so the position of α7 helix can be 
shifted away from the MIDAS. This observation has been exploited to produce αM I-
domain variants that stay in the high ligand affinity form, termed as “active” state. 
Specifically, 7 helix can be truncated from I316 to C terminus to disrupt the 
hydrophobic interactions; similar effects can also be produced with the I316G mutation; 
introduction of a disulfide bond between the 7 helix and the protein core can also 
increase ligand affinity of the domain (22-24). The disulfide bond lock αM I-domain in 
active conformation by pushing down 7 helix, while truncation and mutation of I316 
release the isoleucine from the hydrophobic socket to destabilize the inactive 
conformation. Crystal structures confirm the isoleucine displacement (22). The 
hydrophobic pocket with the buried isoleucine is also observed in the extracellular 
domains of inactive/bent-closed αxβ2 (25). These observations imply that engagement of 
7 helix in the hydrophobic pocket is critical for activation regulation. In fact, 7 helix is 
not the only structural component with mobility. Mutations outside of the hydrophobic 
pocket on the surface close to N/C linkers were also reported to activate integrin αM I-
domains (21). In addition, residues in metal dependent adhesion site (MIDAS) were also 
suspected to be highly dynamic (19,26). This is especially crucial to the promiscuity of 
αM I-domain, which needs to interact with different ligands (27,28). It is thus intuitive to 
assume local conformations in αM I MIDAS are delicately and accurately tuned in an 
adaptive process to expose different residues for respective ligands. The first 
investigation of conformational dynamics in α I-domains using NMR techniques was 
reported by Nunes et al. (29). In their studies, using CPMG relaxation dispersion 
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experiments, µs-ms timescale dynamics were identified for residues in and close to 
MIDAS. They proposed that Mg
2+
 induced dynamics are critical for ligand interactions, 
structural arrangement and functions. As revealed in Chapter 3, significant unequal signal 
intensities were observed for αM I-domain. This is indicative of the occurrence of 
conformational changes at µs-ms time scale. CPMG experiments are well suited for 
investigating dynamics on the slow timescale. Current work focuses on preliminary 
analysis of αM I-domain dynamics with or without Mg
2+
 to probe intrinsic and Mg
2+
 
induced motions. Our data indicate MIDAS residues exhibit strong motions in the µs-ms 
time scale, which is consistent with the need for αM I-domain to interact with different 
ligands. We also noticed that Mg
2+
 binding led to increased dynamics in the α7 helix, 
which may provide mechanistic insights into the effect of divalent cations on integrin 
activation. 
5.3 Materials and Methods 
1, Integrin αM I-domain expression and purification 
 Expression and purification of integrin αM I-domain are previously described in 
Chapters 3 and 4. 
2, CPMG relaxation dispersion (RD) experiments 
 CPMG data were recorded on 600 and 850 MHz Bruker AVANCE spectrometers 
with cryo-probes. Samples contain 0.5-1.0 mM 
15
N integrin αM I-domain and 10% D2O in 
20 mM HEPES, 150 mM NaCl buffer (pH 7.0) with or without 50 mM Mg
2+
. 
15
N RD 
experiments were performed using the relaxation compensated CPMG pulse sequences 
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developed by Loria et al. (30). The constant relaxation delay is 40 ms. Spectra of a 
reference and CPMG field strengths of 100, 150, 200, 250, 300, 400, 600 and 800 Hz 
were collected for apo (No Mg
2+
) samples at 600 and 850 MHz. For 50 mM Mg
2+
 
samples, the CPMG field strengths are 50, 100, 150, 200, 250, 300, 400, 600 and 800 Hz 
on the 600 MHz spectrometer, and 50, 100, 150, 200, 300, 500, 800 and 800 Hz on the 
850 MHz spectrometer. Experiments were repeated for two υCPMG points for error 
analysis. 
RD data were processed with NMRPipe and analyzed with NMRView (31,32). 
Peak intensities were extracted from 
15
N HSQC spectra. R2
eff
 is formulated as the 
equation R2
eff
=1/TCPMG×ln(I0/IυCPMG). I0 and IυCPMG are signal intensity in the reference 
spectrum and signal intensity when CPMG pulse is applied respectively. TCPMG is the 
constant time delay (40 ms). Errors are the propagation of the signal-to-noise ratios of 
repeated measurements. Data were fitted using the GUARDD program (33). GUARDD 
fits data to the Carver-Richards equation, which defines how exchange contribution to 
transverse relaxation (Rex) depends on the frequency of 180° refocusing pulses (υCPMG) 
(34). Fitting follows a two-state model described by the following equations (35):  
𝑅2 (
1
𝜏𝑐
) = 𝑅2
0 +
1
2
(𝑘𝑒𝑥 −
1
𝜏𝑐
𝑐𝑜𝑠ℎ−1[𝐷+𝑐𝑜𝑠ℎ(η+) − 𝐷−𝑐𝑜𝑠ℎ(η−)]) 
𝐷± =
1
2
(
 ±1+
ψ+ 2∆ω
2
(ψ
2
+ 𝜉2)
1
2
)
  
η
±
=
𝜏𝑐𝑝
√2
((ψ
2
+ 𝜉2)
1
2
)
1
2
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ψ 𝑘𝑒𝑥
2 − ∆ω
2
,          𝜉 = −2∆𝜔(𝑝𝐴 − 𝑝𝐵) 
In the above equations, pA and pB are populations for the major and minor states 
respectively. Δω is the chemical shift difference between the two states. kex is the overall 
exchange rate. τcp is the time delay between 180° refocusing pulses (νCPMG=1/2τcp). R2
0
 
is the intrinsic transverse relaxation rate. 
Rex is estimated using the equation: Rex≈ 1/TCPMG×ln(Iτcp1/Iτcp2), where Iτcp1 and 
Iτcp2 are resonance intensities when the highest and lowest CPMG frequencies are 
applied respectively. The approximations of Rex were previously reported (35). 
5.4 Results 
1, µs-ms dynamics in Mg
2+
-free state 
To investigate the intrinsic conformational dynamics of integrin αM I-domain, 
data on the apo sample was first collected. 
15
N CPMG relaxation dispersion analysis is 
well suited to probe µs-ms motions in backbone amide nitrogen atoms (36,37). Without 
Mg
2+
, a number of residues exhibit changes in R2eff under different 180° refocusing pulse 
frequencies (υCPMG). As shown in figure 5.3, residues with high Rex values are mostly 
located in MIDAS (the top surface) and the bottom surface where N and C termini are in 
the apo sample. This is clearly an indication that slow timescale motions exist. Residues 
were first fitted individually and then group-fitted by similar exchange rates and locations. 
The exchanged residues are concentrated in three regions, MIDAS, α7 helix and N/C 
termini region. Figure 5.4 illustrates relaxation dispersion profiles of residue in MIDAS. 
For apo samples, two groups of motions are observed in MIDAS. The first group includes 
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D140, Q204 and E244 while G272 is in the second group. Q204 and E244 are on MIDAS 
loops that contain directly metal coordinating residues. D140 is one of the five 
coordinating residues while G272 is slightly away from metal coordination site. Group 
fitting yields exchange rates (kex) of ~ 700 s
-1
 and ~ 1600 s
-1
 respectively for the two 
groups. Population of the major state (pA) is ~ 94.0 % for the first group and ~ 98.5 % for 
G272. If the molecule has an overall concerted chemical exchange process, CPMG 
fittings would produce similar kex and pA for all exchanged residues. Present results with 
different exchange parameters clearly suggest that multiple dynamics processes exist. 
As shown in Figure 5.5, most residues on α7 helix, don’t display relaxation 
dispersion, except for F317 and A318. L305, I308, Q309 and K315 do not have motions 
in the range (µs-ms) that are detectable in CPMG experiments. F317 and A318 are close 
to the hydrophobic pocket that stabilizes the inactive conformation (22). Group fittings of 
F317 and A318 produce a kex of ~ 240 s
-1
, which represents rather slow motions. pA for 
the two residues is ~ 96.5 %.   
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Figure 5.3 Effects of Mg
2+
 on Rex.  
Upper panels display Rex obtained at 850 MHz from relaxation dispersion 
experiments for apo (gray bars) and 50 mM Mg
2+
(red bars) containing samples. 
Secondary structures of αM I-domain are placed on the top. Lower panel shows the 
ribbon representation of αM I-domain with residues color-coded according to Rex 
values (pdb: 1jlm). 
 
As shown in Figure 5.3, other than MIDAS, some residues in the bottom surface 
of αM I-domain also have high Rex values. CPMG fittings suggest slow dynamics (kex= ~ 
260 s
-1) for K235 and E262 in the bottom surface. E262 is on the α5-β5 loop while K235 
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is on the β4 strand close the hydrophobic pocket of α7 helix. pA for the two residues is ~ 
91.7 %. Relaxation dispersion profiles of the two residues are displayed Figure 5.6. All 
exchange parameter fits can be found in Table 5.1 
2, µs-ms dynamics in Mg
2+
 bound state 
 Previous isothermal titration calorimetry (ITC) analysis (38) and Mg
2+
 
titration in Chapter 3 both suggest that αM I-domain has low affinity for Mg
2+
 (Kd=1.3 ± 
0.3 mM).  50 mM Mg
2+
 was added to αM I-domain samples to saturate Mg
2+
 bindings. 
Just like apo samples, two groups of motions with different exchange rates are also 
identified in MIDAS for Mg
2+
 containing samples, with one group faster than the other. 
Group fittings of D140, Q204 and E244 yields a kex of ~ 1100 s
-1
. G272 in the second 
group has a kex of ~ 2100 s
-1
. MIDAS residues collectively experience faster exchange in 
the presence of Mg
2+
. Effects of Mg
2+
 on MIDAS dynamics are also reflected by 
exchange contributions to transverse relaxation (Rex). For all MIDAS residues, Rex is 
universally higher in apo samples than in Mg
2+
 containing samples. For D140, Q204 and 
E244, all of which are close to the Mg
2+
 binding site, Rex in the apo sample is ~ 2-3 folds 
higher than that of the Mg
2+
 saturated sample. Rex in the apo state is also higher, though 
not as much, for G272, which is distal to Mg
2+
 coordination site. Higher Rex in the apo 
state most likely indicates faster exchange is induced by Mg
2+
.  
 For α7 helix, Mg2+ has more significant effects on conformational dynamics. 
µs-ms motions were observed for many residues along the C-terminal helix in Mg
2+
 
bound state. All residues in Figure 5.5 have shown fast exchange rates at the µs-ms time 
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scale with Mg
2+
. In the first half of the helix, fittings yield a kex of ~ 1500 s
-1
 for F302, 
E303, L305 and Q309. Towards the end of the helix, K315, F317 and A318 are group-
fitted, producing a kex of ~ 1000 s
-1
 and a pA of ~ 98.2%. Comparison of apo and Mg
2+
 
data concludes that Mg
2+
 induces fast dynamics (kex  > 1000 s
-1) throughout α7 helix, 
which is more obvious for the first half of the helix that show no detectable relaxation 
dispersion in apo states. For residues close to the end of the helix, Mg
2+
 increases local 
exchange rates (kex) from ~ 270 to ~ 1000 s
-1
.  This is further supported by increased Rex 
values in the presence of Mg
2+
, as shown in Figure 5.3.  
 Interestingly, just like for MIDAS residues, Mg
2+
 also induces faster exchange 
processes in the bottom surface of αM I-domain. With Mg
2+
, K235 and E262 exhibit an 
exchange rate (kex= ~ 480 s
-1), almost twice as high as what’s observed for apo samples 
(kex= ~ 260 s
-1
). Rex reveals a 3-4 fold decrease when Mg
2+
 is present. This is inconsistent 
with faster exchanges induced by Mg
2+
. pA is ~95.8% for K235 and E262. Relaxation 
dispersion profiles for the two residues are shown in Figure 5.6. All fitted parameters are 
listed in Table 5.1. 
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Figure 5.4 Relaxation Dispersion Profiles of Residues in MIDAS in Apo and Mg
2+
 
Bound States.  
The upper two panels are D140, Q204 and E244 with faster exchange rates (kex) 
than G272 in lower two panels. These four residues are colored red in αM I-domain 
structure (pdb: 1jlm). 
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Figure 5.5 Relaxation Dispersion Profiles of Residues in C-terminal α7 helix in Apo 
and Mg
2+
 Bound States.  
The upper two panels are F302, E303, L305 and Q309 while the lower two panels 
are K315, F317 and A318. These residues are colored red in αM I-domain structure 
(pdb: 1jlm). 
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Figure 5.6 Relaxation Dispersion Profiles of Residues in the Bottom Surface of αM I-
domain.  
K235 and E262 were group-fitted for apo (upper) and Mg
2+
 (lower) samples. The 
two residues are colored red in αM I-domain structure (pdb: 1jlm). 
 
5.5 Discussion 
 Integrin has been extensively studied in structural biology as large scale 
structural rearrangement is involved upon integrin activation (16).  Studies using X-ray 
crystallography, electron microscopy (EM) and super-resolution microscopy revealed 
conformational changes in integrin (25,39-44). As the ligand binding site, α I-domains 
also undergo conformational changes that relay ligand binding signals to the rest of 
integrin molecules (16). Current work focuses on αM I-domain of Mac-1, one of the most 
promiscuous members of the integrin family. MIDAS, as the ligand binding site in αM I-
domain, was found to expose different sets of residues for different ligands (27). In order 
to selectively present residues, MIDAS needs to be highly dynamic to adopt multiple 
local conformations. So far the only NMR CPMG relaxation dispersion analysis on α I-
domains is on α1 I-domain. In that study, Mg
2+
 was found to induce µs-ms motions on 
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MIDAS residues and residues close to a salt bridge distal to MIDAS. It turns out that 
these dynamics are functional as mutations of the exchanged residues affect collagen 
bindings of α1 I-domain (29). This study serves as a model to explore and compare the 
conformational dynamics of αM I domain with α1 I-domain. 
Table 5.1 GUARDD Group Fits of 
15
N CPMG Relaxation Dispersion Curves 
Recorded at 600 and 850 MHz for Apo and Mg
2+
 Bound Samples of Integrin αM I-
domain. 
MIDAS residues are labeled with asterisks (*); α7 helix residues are labeled with 
daggers (†); Residues in the N/C bottom surface are labeled with double-daggers (‡). 
 kex (s
-1
) pA(%) Residue 
(
15
N) 
Rex (s
-1
) 
600 MHz 
Rex (s
-1
) 
850 MHz 
Δω N 
(ppm) 
Apo 702.6 ± 169.5 94.0 ± 5.5 D140* 25.2 ± 5.2 40.8 ± 7.0 1.9 ± 0.5 
Q204* 16.9 ± 1.8 28.4 ± 1.6 1.5 ± 0.3 
E244* 14.5 ± 1.4 22.2 ± 1.6 1.6 ± 0.3 
1627.3 ± 702.4 98.5 ± 17.3 G272* 5.9 ± 0.9 11.7 ± 0.8 2.6 ± 1.4 
276.3 ± 196.7 96.5 ± 17.0 F317† 3.5 ± 0.6 5.0 ± 0.4 1.1 ± 0.8 
A318† 3.6 ± 0.3 7.7 ± 0.2 1.0 ± 0.9 
267.3 ± 122.0 91.7 ± 9.4 K235‡ 18.1 ± 1.8 25.3 ± 1.5 1.7 ± 0.5 
  E262‡ 19.2 ± 1.6 30.9 ± 1.3 1.6 ± 0.3 
Mg
2+
 
bound 
1163.2 ± 307.9 96.7 ± 9.7 
 
D140* 12.2 ± 4.2 15.6 ± 5.8 2.7 ± 0.9 
Q204* 3.4 ± 0.8 8.0 ± 1.0 1.4 ± 0.6 
E244* 3.6 ± 0.7 4.5 ± 0.9 1.1 ± 0.3 
2162.7± 1416.0 78.7 ± 18.8 G272* 4.7  ± 1.0 8.2 ± 1.3 0.8 ± 1.5 
1499.3 ± 166.2 70.0 ± 19.1 F302† 8.5 ± 0.9 10.6 ± 0.9 0.6 ± 0.4 
E303† 5.4 ± 1.4 7.5 ± 1.9 0.6 ± 0.4 
L305† 4.9 ± 0.7 5.7 ± 0.9 0.4 ± 0.2 
Q309† 4.1 ± 0.5 6.6 ± 0.6 0.5 ± 0.3 
982.7 ± 194.6 98.2 ± 0.5 K315† 2.8 ± 0.3 4.7 ± 0.4 1.6 ± 0.2 
K317† 4.8 ± 0.5 6.5 ± 0.7 1.8 ± 0.2 
A318† 4.6 ± 0.4 7.1 ± 0.5 2.1 ± 0.3 
485.2 ± 112.4 95.8 ± 7.2 K235‡ 5.6 ± 1.0 8.2 ± 1.0 1.1 ± 0.2 
E262‡ 2.7 ± 0.8 4.3 ± 0.6 0.7 ± 0.1 
 
 Our CPMG analysis of αM I-domain reveals µs-ms dynamics of MIDAS 
residues in both apo and Mg
2+
 containing samples. This means that the µs-ms motions are 
inherent in αM I MIDAS, which is different from α1 I MIDAS, which only exhibit slow 
time scale motion after Mg
2+
 binding (29). Just like α1 I dynamics is consistent with the 
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Mg
2+
-dependent mechanism of α I-ligand interactions (16), the intrinsic dynamic nature 
of αM I-domain may be crucial to the ligand promiscuity of the domain. However, there 
may be multiple ligand interaction mechanisms for the promiscuous Mac-1. For example, 
as discussed in Chapter 4, αM I-domain interacts with cationic ligands in a newly 
discovered Mg
2+
 independent mechanism. The novel findings imply that motions, 
existing in MIDAS regardless of Mg
2+, are possibly functional for αM I-domain’s ligand 
interactions. To summarize, current results confirm that µs-ms conformational dynamics 
in αM I MIDAS are intrinsic and present even without Mg
2+
. 
 Although α7 helix motions were not discovered in α1 I (29), they are 
significant in αM I-domain. In Figure 5.4, other than F317 and A318, most residues in the 
C-terminal helix do not have relaxation dispersion in apo samples. F317 and A318 indeed 
display slow exchange rates (kex ~ 240 s
-1
). Immediately preceding them is I316, which 
does not exhibit any relaxation dispersion effect. This is consistent with the fact that the 
residue is wedged in a hydrophobic pocket in the inactive conformation (22). In contrast, 
Mg
2+
 induces fast ( > ~1000 s
-1) motions for an expanded list of residues in α7 helix. 
Movement of the C-terminal helix is considered a crucial event that links the α I-domain 
conformational changes with global structural rearrangements in integrin molecules (16). 
The movement, ascertained by crystal structures, activates α I-domains (18,19). Current 
data supports the C-terminal helix mobility as Mg
2+
 induced fast dynamics spreads out 
along the helix. Studies have also indicated that divalent metal ions such as Mg
2+
 activate 
integrin and enhance α I-ligand interactions (16,45,46). It is likely that Mg2+ induced fast 
dynamics on the α7 helix is essential to ligand bindings and activation of the entire 
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protein that follows. More dynamics and functional studies can be done to investigate the 
C-terminal helix motions. 
 In the bottom of αM I-domain, slow motions (K235 and E262) were 
discovered, which are not found in α1 I-domain (29).  When Mg
2+
 is present, kex for these 
two residues is almost 2-fold higher than in the apo state. The bottom surface is on the 
opposite side from the ligand binding MIDAS. αM I-domain is covalently attached to β 
propellers through N and C linkers in the bottom (16). It is also the interface of α and β 
subunits (16). Studies using activation-specific antibodies manifested that mutations in 
the bottom surface activate Mac-1 and increase ligand affinities (21). These activating 
mutations are actually very close to F235 and E262. It is possible that motions in the 
bottom region are crucial for activation. However, it is not clear how the bottom surface 
motions exactly contribute to activation and what regulatory roles the Mg
2+
 induced 
motions play. Further work is needed to confirm the functionality of the bottom dynamics. 
It should be noted that homodimeric interactions between MIDAS and N/C termini 
region (bottom) may exist, although much weaker in the current N/C truncated version, 
which is discussed in Chapter 3. It is not known if the bottom dynamics is a result of the 
weak homodimeric interactions. 
 Data fittings from GUARDD program reveal that kex values are systematically 
higher in the presence of Mg
2+
, meaning Mg
2+
 bindings produce faster motions in αM I-
domain. This is consistent with Rex values obtained for the apo and Mg
2+
 bound states. As 
displayed in Figure 5.3, most residues have larger Rex values in the apo state with the 
only exception being residues in α7 helix, whose Rex values are consistently smaller in 
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the apo state. Apparently, motions of most residues are in the µs-ms range in the apo state 
and become faster upon Mg
2+
 addition. However, with no Mg
2+, α7 helix is likely to be 
rigid, therefore has low Rex values. Mg
2+
 induced more motion in the helix, bringing kex 
to the µs-ms range, which leads to relaxation dispersions and larger Rex in α7 helix. To 
conclude, the Rex plots suggest: 1, slow motions are intrinsic in αM I-domain; 2, Mg
2+
 
binding produce overall faster dynamics, including µs-ms motions in α7 helix. All these 
are consistent with the exchange parameters from fitting analysis (Table 5.1). 
 Due to the large scale conformational rearrangements, integrins and α I-
domains are excellent models of protein dynamics studies (16). However, much is 
unknown about how protein motions are related with ligand bindings and global 
structural changes during integrin activation. Present investigations on αM I-domain 
provide preliminary analysis of µs-ms dynamics using CPMG experiments. We 
unraveled motions unique for αM I-domains, which are intrinsic dynamics in the MIDAS 
and the bottom surface, and Mg
2+
 induced dynamics in α7 helix. As to how these 
dynamics processes actually contribute to functions of αM I-domains and Mac-1, more 
work is needed. This may involve mutating residues in MIDAS to modulate dynamics 
and monitor their effects on ligand affinity and/or ligand selectivity. Exchanged residues 
in α7 helix can be mutated in mammalian cells to probe whether cell adhesions and 
migrations are changed. In our studies, ps-ns range dynamics of αM I-domain are missing 
as CPMG is tailored to probe slower µs-ms range dynamics only. In order to fill the gap, 
model-free S
2
 analysis should be performed to explore the effects of Mg
2+
 on motions of 
such timescales (7,8). 
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CHAPTER 6 
SUMMARY AND OUTLOOK 
Work in the thesis aims to investigate interactions of glycosaminoglycan (GAG) 
binding proteins with their proteoglycan and non-proteoglycan receptors from a structural 
biology perspective. GAG-binding proteins (GBPs) encompass a variety of proteins with 
different biological functions, such as chemokines, growth factors and extracellular 
matrix (ECM) proteins (1). Such diverse families of proteins interact with various 
partners, including GAGs as well as other proteins. Chapter 2 explores GAG interactions 
of decorin binding protein B (DBPB). Chapters 3-5 discuss integrin αM I-domain as a 
receptor for positively charged pleotrophin (PTN) and platelet factor 4 (PF4), which are 
GBPs. 
6.1 Decorin Binding Protein B (DBPB) Interactions with GAGs. 
The first structure of B31 DBPB structure was determined with NMR. Using 
biochemical and biophysical methods, lysine-rich C terminus was identified as the GAG-
binding epitope. However, soluble mature form of DBPB was used here without the N-
terminal triacyl-modified cysteine (2). The lipidation sequence anchors DBPs onto the 
spirochaete outer membrane. Lipidated form of DBPB may have different structures 
and/or oligomerization status from soluble unlipidated form. Although lipidation effects 
on DBPB are poorly understood, one study showed that the lipidated version of DBPA 
has considerably higher affinity for decorins than the unlipidated verion (3). Future work 
should be focused on the effects of lipidation on DBPB-GAG interactions. Current work 
indicated similar GAG affinities of DBPA and DBPB. However, DBPA is less conserved 
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in sequence than DBPB (4-6). Despite contributing similarly to infectivity, DBPA and 
DBPB have different effects on bacterial dissemination and tissue colonization (7). 
Further investigations using lipidated proteins may lead to deeper understandings of what 
contributes to the difference in virulence and overall infection. 
6.2 Pleiotrophin and Platelet Factor 4 Interactions with Integrin αM I-domain. 
Pleiotrophin (PTN), a cytokine, and platelet factor 4 (PF4), a chemokine, are both 
highly positively charged proteins that bind GAGs strongly (8) (9). Current investigations 
revealed that the two cationic proteins interact with integrin αM I-domain in a novel 
Mg
2+
-independent mechanism. In particular, PTN and PF4 both bind to the metal ion 
dependent adhesion site (MIDAS) in αM I-domain, a site commonly used to bind ligands 
in a metal-mediated fashion. However, binding of these cationic ligands at MIDAS does 
not require Mg
2+
 at all. In addition, PF4 interaction does not induce conformational 
change in αM I-domain. It would be insightful to probe if intact integrin Mac-1 changes 
conformations upon PF4 or PTN binding. Atomic level structures of αM I-PTN/PF4 
complex would also provide more details of the interactions. 
6.3 Integrin αM I-domain Conformational Dynamics. 
 Integrins are known to have multiple conformations. Many of these significant 
conformational changes take place in the α I-domains (10-17). Using NMR relaxation 
dispersion experiments, intrinsic µs-ms motions in MIDAS residues were observed. In 
addition, Mg
2+
 induced increases in the kinetics of the motion in residues throughout the 
protein, but especially in αM I MIDAS and α7 helix respectively. This is different from 
the observations on α1 I-domain in which only Mg
2+
 induced µs-ms motions in MIDAS 
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were detected (18). It is not clear if the unique dynamics of αM I-domain is functionally 
relevant. More work needs to be done to examine changes in ligand affinity in mutants 
lacking the dynamics. Studies also suggested that mutations in the bottom surface of αM 
I-domain promote active conformations and ligand interactions (19). Whether the bottom 
mutations activate αM I-domain by stimulating any dynamic processes is unknown. NMR 
relaxation dispersion experiments could be performed to investigate the effects of the 
bottom mutations on conformational dynamics of αM I-domain. As α7 helix movement is 
a key event that connects conformational change of α I-domain to the global structural 
rearrangement of integrin proteins (17), it will be of great interest to probe the effects of 
the mutations on the conformational flexibility of intact integrins on cell surface. In 
particular, these mutations may change the potential energy required to convert the 
integrin from the bend to the extended conformation. Recent advances in super-resolution 
microscopy make it possible to perform optical measurements of conformational changes 
on such a large scale in integrins (20).  
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Figures 2S1 
1
H-
15
N HSQC overlays (upper panel) of WT DBPB titrated with DS 
dp10 and fitting curve (lower panel) of residue K184. Contours are color-coded with 
increasing concentrations of GAG fragments (0, 0.2, 0.6, 1.0, 1.4, 1.8 and 2.2 mM). 
The sample contains 400 uL of 100 uM protein in 50 mM NaH2PO4 and 150 mM 
NaCl buffer (pH 6.5). K184 is displayed with an arrow indicating migration 
direction. 
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Figures 2S2 DS-induced DBPB conformational exchange characterized by CPMG-
based relaxation dispersion experiments. (A) Residue specific Rex values derived 
from the experiment. Rex is taken as the difference between R2,eff values at field 
strengths of 10 and 210. (B) Changes in R2,eff of residues G55 and T66 as field 
strength increases. 
 
Figure 2S3 DBPB titrations with heparin dp6. (A) 
1
H-
15
N HSQC overlays of WT 
B31 DBPB with increasing concentrations of heparin dp6. Signals with large 
migrations are labeled with their residue numbers and arrows to indicate migration 
directions. (B) Fitting curves of DBPB residues S72 and K185 when titrated with 
heparin dp6.  
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Figure 2S4 Backbone dynamics of DBPB in the presence and absence of heparin 
dp10. Order parameters of backbone amide nitrogen atoms for WT B31 DBPB with 
(red) or without (black) 10 molar equivalents of heparin dp10. 
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Figures 2S5 
1
H-
15
N HSQC overlays (A) K65S/K69S DBPB. (B) R78S/K81S 
DBPB. (C) K81S/K169S DBPB. (D) 
184
SSS
187
 DBPB. (E) DBPB21-183. 
Contours are color-coded with increasing concentrations of GAG fragments 
(0, 0.2, 0.6, 1.0, 1.4, 1.8 and 2.2 mM). The sample contains 400 uL of 100 uM 
protein in 50 mM NaH2PO4 and 150 mM NaCl buffer (pH 6.5). Residues 
S72 and K185 were used in the Kd calculations. 
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Figure 2S6 Kd binding curves of DBPBs. Kd fittings were obtained for NMR-
monitored titrations using xcrvfit 
(http://www.bionmr.ualberta.ca/bds/software/xcrvfit/). 
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Figure 2S7 (A) Results of heparin and DS ELISA comparing the GAG affinities of 
B31 DBPA and DBPB. The two proteins have equal affinities for native heparin and 
DS. (B) Heparin dp6 GMSA of B31 DBPA and DBPB. Both proteins’ affinities for 
size defined heparin are also similar. 
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SUPPLEMENTAL FIGURES OF CHAPTER 4 
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Figure 4S1 Effects of ionic strength on αM I-domain’s interactions with PTN and 
PF4. (A), MST-derived binding curves for interactions of PTN with Dylight 488 
labeled αM I-domain at ionic strength of 100 mM and 200 mM. (B), MST-derived 
binding curves for interactions of PF4 with Dylight 488 labeled αM I-domain at 
ionic strength of 100 mM and 200 mM. 
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Figure 4S2 Effects of free MTSL on HSQC of αM I-domain. 
15N HSQC of αM I-
domain in the presence of 0.9 mM of paramagnetic (blue) or diamagnetic (black) 
MTSL. Free MTSL alone has little effect on signal intensity of G143, G207 and 
G247. 
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Figure 4S3 Mg
2+
 induced residue specific chemical shift changes in αM I-domain. 
(A), Chemical shift changes are calculated as √∆H𝟐 + (𝟎.𝟐𝟓 ∗ ∆N)𝟐 . Secondary 
structures of αM I-domain as well as residues and regions forming the MIDAS are 
indicated on top of bar charts. (B), Ribbon representation of αM I-domain showing 
positions of residues with significant Mg
2+
-induced chemical shift changes. 
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APPENDIX D 
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APPENDIX E 
PERMISSION FOR TABLE 1.2 
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APPENDIX G 
PERMISSION FOR FIGURE 1.3 
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APPENDIX H 
PERMISSION FOR FIGURE 1.4 
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APPENDIX I 
PERMISSION TO REPRODUCE CHAPTER 2 FROM BIOCHIMICA ET 
BIOPHYSICA ACTA (BBA)-PROTEINS AND PROTEOMICS 
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